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ABSTRACT 
 
Composite materials have recently been introduced as versatile systems for 
embedding functional microdomains within moldable hydrogels. Potential applications 
for these materials include optical biosensing, drug delivery, and anti-corrosion agent 
releasing smart coatings, wherein the microdomains comprise regions that contain active 
molecules bound by nanofilms that possess precisely-tailored transport properties.  
In this work, composite hydrogels are investigated as sensing materials, with a 
focus on controlling analyte permeation into the internal microdomains. Transport of 
glucose across cross-linked PAH [poly (allylamine hydrochloride)] / PSS [poly (sodium 
4-styrenesulfonate)] bilayers deposited on planar substrates was studied to evaluate the 
potential of ultrathin films to limit small-molecule diffusion. The nanofilm design was 
translated onto calcium carbonate colloidal templates to fabricate hydrogels that contain 
functional microdomains in order to demonstrate a “tunable” enzymatic biosensor. By 
varying the number of cross-linked and non-cross-linked bilayers deposited, the response 
characteristics of the hydrogel based sensors were successfully modulated; however, 
these sensors exhibited poor stability, prohibiting long term use. 
Alginate microparticles containing either glucose sensing or lactate sensing 
chemistry coated with similar nanofilms were explored as an alternative colloidal 
template. Response of both glucose and lactate sensing hydrogels fabricated using 
alginate microparticles was evaluated at ambient oxygen levels and physiologically 
relevant low oxygen concentrations; this work demonstrated the operation of hydrogel 
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based enzymatic sensors at in vivo oxygen levels for the first time. Additionally, these 
sensors showed exceptional stability when used continuously, supporting their potential 
as long term implantable sensors. Furthermore, cooperative effect between biosensing 
micro- and macro- domains was carefully examined to study the limits of hydrogel based 
sensors for multiplexed and multianalyte sensing. Additionally, novel gold nanocluster 
containing microcapsules were explored as hydrogen peroxide sensors for potential 
coimmobilization in composite hydrogel based enzymatic sensors to monitor levels of 
hydrogen peroxide release over time; hydrogen peroxide is a byproduct produced in 
enzymatic glucose and lactate sensors that causes sensor failure.  
The results demonstrate significant advances in the field of fully implantable 
composite hydrogel based devices; especially methods to control the permeation of 
analytes into bioactive microdomains in order to obtain stable sensor response at 
physiologically low oxygen levels. The knowledge gained from this study will serve as a 
guide to fine-tune and optimize composite biosensing hydrogels, after gaining additional 
information post-implantation in animal models.   
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1. INTRODUCTION  
  
 Chronic diseases have become one of the major causes of disability and death, 
with over 50% of the United States’ adult population afflicted with one or more chronic 
conditions.1 Cardiovascular diseases, cancer, obesity, diabetes, malignant neoplasms, 
and cerebrovascular diseases are some of the most common chronic conditions.2 The 
financial burden of these diseases is tremendous with over 86% of healthcare dollars 
spent; cancer, heart conditions, and diabetes being the top contributors to healthcare 
spending.3 There are a few key risk factors that contribute to these diseases, which 
include lack of physical activity, poor diet, tobacco use, excessive alcohol consumption, 
and uncontrolled hyperlipidemia and hypertension. 4, 5 Many of the risk factors and the 
resulting ailments can be addressed through policy changes, community programs, 
educational sessions, and technological innovations for monitoring biomarkers. 
Continuously monitoring biomolecules characteristic to chronic conditions using 
implantable biosensors can potentially mitigate the progression of such diseases and 
assist in better disease management especially when coupled with corrective therapeutic 
measures. 
 Invention of the Clark and Lyon’s electrode based sensors marked the beginning 
of an era of biosensing.6 Most of the biosensors had been initially used for laboratory 
purposes but with advances in commercial manufacturing and with active interest from 
big diagnostic and pharmaceutical companies, home-based consumer use of biosensors 
have become increasingly popular leading to over $13 billion US dollars in revenue.7 
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Glucose biosensors in particular dominate the biosensor market and are responsible for 
over 85% of the market share.7 The most common method of home-based glucose 
sensing involves measuring blood glucose levels from blood drawn using a small lancet. 
Although this finger-prick method is highly sensitive and specific to glucose, it is marred 
by certain drawbacks. The finger-prick method only allows discrete glucose 
measurements revealing only a partial picture of diurnal glucose fluctuations that might 
lead to inaccurate therapeutic counter measures potentially resulting in life threatening 
glucose levels.  Tracking glucose levels continuously using subcutaneous implantable 
sensors offer a better and more effective means to manage diabetes. Several such Food 
and Drug Administration (FDA) approved implantable electrode-based sensors have 
been commercialized.8 However, the longevity of these needle-type implantable sensors 
are short lived requiring frequent replacements by users. This is primarily due to implant 
induced foreign body response, ultimately leading to complete sensor failure within a 
week of operation.9  
 Alternatively, hydrogel based fully implantable biosensing devices may be used 
for continuous biomarker tracking. Soft hydrogel based biosensors can potentially 
circumvent the problems associated with needle-type implantable sensors including 
repetitive tissue trauma, infections, and fibrous capsule induced sensor failure.10, 11 
Implanted hydrogels serve a dual purpose of housing sensing elements and of providing 
a biocompatible interface to minimize host response. However, it is imperative to 
consider the tradeoff between biocompatibility and analyte response characteristics. 
These biosensors are enzyme based catalytic devices that rely on the consumption of 
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glucose; therefore, any attempt to modify the hydrogel matrix to improve 
biocompatibility can adversely affect the passage of analytes making it extremely 
difficult to generate a reliable sensor response. Nevertheless, biocompatibility and 
analyte flux can be dealt with independently by segregating the sensing chemistry into 
micro-sized, nanofilm lined, bioactive domains that are then dispersed in an outer 
hydrogel matrix.  
 This unique hydrogel based nanocomposite architecture has been demonstrated 
for use as optical oxygen sensors using encapsulated phosphorescent dye.12 Theoretically 
inclusion of an oxidoreductase enzyme (e.g. glucose oxidase, lactate oxidase) along with 
oxygen sensitive phosphors within nanofilm lined microdomains can transform these 
hydrogels into optical enzymatic sensors. However, the nanofilm design and 
composition requires special optimization specific to each analyte of interest. The high 
surface area to volume ratio of these microdomains makes the prevention of substrate 
diffusion challenging, as diffusion lengths are on the orders of nanometers. Furthermore, 
these devices depend upon local oxygen levels; as in vivo oxygen concentration is four 
times lower than ambient levels it makes analyte transport requirements even more 
stringent. Properly designed, these hydrogel based devices can be used as multianalyte 
and multiplexed sensors.  
 This dissertation has been organized to describe the development of novel 
hydrogel based enzymatic sensors for single analyte and multianalyte sensing. Section 2 
provides a general background about glucose monitoring, particularly using enzymatic 
biosensors. Section 3 describes the use of crosslinked nanofilms to control the 
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permeation of glucose into composite hydrogel based glucose sensors, in order to 
manipulate the sensor’s range and sensitivity; portions of this section have been 
published in RSC Advances. Section 4 and Section 5 explains the development of 
nanofilm bound alginate microsphere based composite hydrogels for stable detection of 
glucose and lactate at low physiological oxygen concentrations respectively. Portions of 
Section 4 have been published in MDPI Biosensors. Section 6 discusses and 
demonstrates the limitations and uses of composite hydrogel based enzymatic sensors for 
multianalyte and multiplexed sensing. Section 7 describes the development of a new 
method to fabricate gold nanocluster containing optical microcapsule sensors for 
hydrogen peroxide detection, which can be potentially used to monitor enzymatic 
reactions in hydrogel based biosensors; these microcapsules can also be used for 
intracellular hydrogen peroxide sensing that has been demonstrated and described in 
Appendix A. Portions of Section 7 and Appendix A have been published in ACS Omega. 
Finally, Section 8 discusses the major conclusion, limitations, and possible future 
direction. 
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2. BACKGROUND 
 
2.1. Diabetes 
 Diabetes is a chronic condition characterized by the body’s inability to regulate 
physiological blood glucose levels. An estimated 422 million adults globally and almost 
a tenth (~ 9.3%) of the US population are affected by diabetes; accounting for over $240 
billion in healthcare costs in the US (2012).13, 14 Insufficient production of insulin (a 
hormone that lowers blood glucose levels) or failure to successfully utilize insulin leads 
to diabetes. Type 1 diabetes is characterized by destruction of pancreatic beta cells by 
the body’s immune system; beta cells are specialized cells that produce insulin. Type 1 
diabetes is largely considered as a genetic disorder that is triggered by environmental 
factors. Type 2 diabetes is the most prevalent form and is due to insulin resistance, a 
situation where muscle, liver, and fat cells cannot efficiently utilize insulin. A 
combination of unhealthy lifestyle, lack of physical activity, and genetic predisposition 
contributes to Type 2 diabetes. Gestational diabetes is another common form of diabetes 
caused by insulin resistance that affects women during pregnancy. Uncontrolled and 
without proper management, diabetes can lead to life threatening circumstances over 
time. For example, incorrect medication dosage, stress, and exhaustion can decrease 
blood glucose (hypoglycemia) to dangerously low levels that might lead to loss of 
consciousness, seizures, or even coma. Hyperglycemia, on the other hand can trigger 
potentially fatal ketoacidosis or hyperosmolar coma. Additionally, sustained 
hyperglycemia can cause irreversible damage to nerves, kidneys, eyes, and heart.15 
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2.2. Monitoring diabetes 
 Proper control and management of blood glucose can prevent the progression of 
diabetes and its associated secondary complications. Effective glycemic control requires 
measuring blood glucose at regular intervals coupled with orally administered drugs (e.g. 
metformin, gliclazide) or injected insulin to maintain normal glucose levels (80 – 130 
mg/dL). The most common method of home glucose monitoring involves drawing a 
drop of blood from the patient’s fingertip using a lancet, followed by transferring the 
blood onto a disposable test strip that is ultimately inserted into a glucose meter to 
calculate glucose concentration. Although these devices are extremely accurate 16 they 
are unable to track changes in glucose throughout the day due to patient noncompliance. 
Cost of supplies and pain aversion are the main reasons that contribute to patient 
noncompliance. Thus, fully implantable continuous monitoring sensors provide a better 
alternative that does not require frequent manual measurements. 
 
2.2.1. Commercially available continuous glucose monitoring system 
  Commercial available continuous glucose monitoring systems (CGMSs) consist 
of a tiny implantable metallic electrode coated with immobilized glucose oxidase (GOx); 
GOx catalyzes glucose to produce hydrogen peroxide that is amperometrically detected 
by the electrode.17 These devices measure glucose every 1 – 5 min providing real-time 
information and therefore help preventing frequent episodes of hyperglycemia or 
hypoglycemia.18, 19 Additionally, CGMSs have long term benefits of lowering HbA1c 
(glycated hemoglobin) levels.20 Currently there are four FDA approved CGMSs 
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available to US consumers manufactured by Dexcom and Medtronic. Additionally, 
remote monitoring capability in CGMSs has been an emerging feature and can transform 
diabetes care; these devices can wirelessly transmit real-time data to physicians or 
relatives allowing even tighter glycemic control. 21, 22 
 
2.2.2. Foreign body response (FBR) 
 Foreign body response is the body’s innate inflammatory response to an 
implanted sensor that ultimately leads to complete sensor failure. As soon as the device 
is implanted it causes local wounding and comes in contact with the host physiology 
initiating inflammation. The inflammatory response starts with accumulation of 
coagulated proteins and platelets, and progresses with the recruitment of inflammatory 
cells eventually leading to fibrosis. Inflammation may either lead to damage of sensor 
components or formation of a fibrous biomembrane that encapsulates the sensor. In 
order to be detected accurately an analyte should have unhindered access to the 
implanted sensor. However, formation of a biofouling membrane limits diffusion of the 
analyte of interest decreasing sensor performance over time eventually causing total 
sensor failure.23 Although frequent calibrations may compensate for reduced sensor 
performance,24 most sensors fail within 3 – 7 days.9 
 A number of strategies may be used to combat FBR and prolong a sensor’s 
operational lifetime. The most common methods to extend a sensor’s longevity involve 
coating the sensor surface with a biocompatible material (e.g. tetraglyme, phospholipid, 
albumin, hydrogel overlays, Nafion), manipulating the implanted sensor’s surface 
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topology, or via the release of anti-inflammatory drugs (e.g. dexamethasone, nitric 
oxide).25 Alternatively, completely hydrogel based fully implantable sensors that 
preclude the use of metallic electrodes have been gaining interest over the years. Owing 
to their low biofouling and biomimetic properties FBR is minimal23, 26 engendering the 
use of hydrogels in the form of fibers, microparticles, and slabs 27-29 as biosensors. 
 
2.3. Optical sensing 
 Advances in optical spectroscopy and optics instrumentation has led to rapid 
development of several optical sensing technologies that have been used for process 
control, remote sensing, and biomedical applications.30 Optical sensors function via 
registering changes in at least one of the several optical parameters (refractive index 
polarization, scattering, reflectance, absorbance, fluorescence) in response to the analyte 
of interest. Infrared absorption spectroscopy,31 thermal infrared measurements,32 Raman 
scattering,33 polarimetry,34 and coherence tomography35 are some of the non-invasive 
techniques that have been explored for use in glucose sensing. However, none of these 
methods have been successfully translated for commercial use due to their low signal-to-
noise ratio and poor selectivity.35 Fluorescence based techniques are highly sensitive and 
specific, offering a superior alternative. Unlike other methods, fluorescent based sensors 
are not affected by changes in intrinsic scattering or absorption properties of glucose. 
Moreover, the ready availability of cheap visible light emitting diodes and highly 
sensitive photodetectors have led to increased interest focused on developing fluorescent 
methods for sensing glucose and other relevant biomarkers. These sensors can be further 
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classified as bioaffinity or biocatalytic sensors based on their mode of glucose 
recognition.36 
 
2.3.1. Bioaffinity based sensors 
 Bioaffinity sensors reversibly bind to an analyte of interest and produce a change 
in optical signal that is ultimately used to detect fluctuations in analyte concentration. A 
single fluorescent dye or a pair of fluorescent dyes can be employed to monitor such 
analyte mediated binding events.37 Different receptors have been investigated to develop 
affinity based sensors; the most commonly used glucose receptors include apo-glucose 
oxidase,38 glucose binding protein39 and boronic acid derivatives.40, 41 A subset of 
bioaffinity sensors are based upon competitive binding of a ligand (analyte) and a ligand 
analogue, to a ligand receptor; for example competitive binding of glucose and dextran 
to concanavalin A has been thoroughly studied for glucose sensing.36, 42 Affinity based 
systems are independent of analyte diffusion rates, substrate consumption, or detrimental 
product formation making them attractive candidates for sensing. However, long term in 
vivo use of most of these systems with the exception of boronic acid derivatives are 
limited due to conformational instability over time. Senseonics recently demonstrated 
diboronic acid based highly sensitive and extremely accurate continuous glucose sensing 
in humans that lasted for 3 months.43 
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2.3.2. Biocatalytic (Enzymatic) sensors 
Biocatalytic sensors are the most common forms of sensors that utilize either 
glucose oxidase or glucose dehydrogenase as the bioactive element to catalyze glucose. 
The sensing scheme may be direct or indirect; indirect sensing measures changes in pH, 
oxygen, or H2O2 with increase in glucose. 
 
2.3.2.1. Direct sensing 
 Enzymatic optical sensors typically detect analyte levels indirectly by monitoring 
cosubstrate consumption or by-product formation; however, there are a few examples of 
direct fluorescence based enzymatic sensing. Direct enzymatic optical sensing utilizes 
either the intrinsic fluorescence of the analyte-catalyzing enzyme or the fluorescent 
properties of a probe attached to the enzyme. Hussain et al. demonstrated direct glucose 
sensing using intrinsic fluorescence of yeast hexokinase; hexokinase has inherent UV-
fluorescence (excitation/emission at 295/330 nm) that is quenched in the presence of 
glucose. 44 Similarly, the fluorescence of flavin adenine dinucleotide (FAD) has been 
used for glucose sensing.45, 46 FAD is a coenzyme of GOx, with strong green 
fluorescence (excitation/emission at 450/520 nm) that increases with glucose addition. 
Glucose dehydrogenase (GDH) was also reported for direct glucose sensing, where the 
blue fluorescence (excitation/emission at 340/460 nm) of its cosubstrate nicotinamide 
adenine dinucleotide (NADH) linearly increased with glucose.47 Although these methods 
do not require the additional step of tagging the glucose-converting enzyme with a 
fluorescent probe, they are marred by low sensitivity and low signal-to-noise ratio 
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issues. These issues can be circumvented by attaching highly fluorescent probes to the 
enzymes. GOx has been derivatized with different fluorescent molecules for direct 
sensing applications. Coumarin tagged GOx has been shown to be responsive to glucose; 
GOx-coumarin’s blue fluorescence increases with rise in glucose levels.48 Alternatively, 
fluorescein labelled GOx that takes advantage of energy transfer between fluorescein 
and GOx’s FAD group has also been demonstrated for sensing glucose.49, 50 
 
2.3.2.2. Indirect sensing 
 Indirect enzymatic sensing consists of tracking co-substrates consumed or by-
products formed as a result of enzymatic reactions. The enzymes involved are usually 
oxido-reductase in nature that catalyze reactions with high specificity, producing 
products or consuming reactants that can be detected using optical transducers. Such 
sensors have been developed for the detection of different bioanalytes (e.g. glucose, 
lactate, cholesterol, urea, ethanol) and have found use across various industries. The 
most extensively investigated enzymatic sensor oxidizes glucose in the presence of GOx 
via the following reaction: glucose + O2 + H2O  →  gluconic acid + H2O2. By 
monitoring the depletion of oxygen or the formation of products (i.e. gluconic acid or 
hydrogen peroxide) glucose concentrations can be indirectly inferred. Gibson et al. 51 
described this reaction using the following set of reaction equations: 
GOxox + G 
𝑘1
→  GOxred GDL 
k2
→ GOxred + GDL  
GOxred + O2  
𝑘3
→  GOxoxH2O2   
k4
→ GOxox + H2O2  
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where G, GDL, O2, H2O2, GOxox, GOxred, and kn represents glucose, glucono-δ-lactone, 
oxygen, hydrogen peroxide, oxidized form of GOx, reduced form of GOx, and the 
reaction rates respectively. Similarly, optical transduction can also be used to 
enzymatically detect lactate using lactate oxidase (lactate + O2 + lactate oxidase + H2O  
→  pyruvate + H2O2). The kinetics of this reaction can also be represented by the 
following: 
LOxox + L 
𝑘1
→  LOxred pyruvate 
k2
→ LOxred + pyruvate  
LOxred + O2  
𝑘3
→  LOxoxH2O2   
k4
→ LOxox + H2O2  
where L, O2, H2O2, LOxox, LOxred, and kn represents lactate, oxygen, hydrogen peroxide, 
oxidized form of lactate oxidase, reduced form of lactate oxidase, and the reaction rates 
respectively. 
 
2.3.2.2.1. Optical pH transduction  
 Changes in pH can be optically detected to transduce glucose levels; pH can be 
detected directly using an optical probe (e.g. dye, nanoparticle) or indirectly by 
monitoring hydrogel swelling kinetics using fluorophores. Hydroxypyrene trisulfonate 
(HPTS) a pH sensitive dye has been used for the development of optical fiber based and 
microcapsule based enzymatic glucose sensors.52, 53 Similarly, fluorescein isothiocyanate 
(FITC) has also been used as a pH indicator coupled to GOx to fabricate optical fiber 
based sensors.54 Recently, soft hydrogel based sensors that indirectly detect glucose 
using pH sensitive fluorescent dyes and pH sensitive Raman reporters have been 
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reported by McShane’s group.11, 55 When glucose enters these hydrogels glucose is 
oxidized by GOx, releasing gluconic acid that can be optically detected by SNARF or 
mercaptobenzonic acid capped gold nanoparticles. Alternatively, pH can swell or 
deswell a hydrogel that can be optically tracked and utilized to make enzymatic sensors; 
rhodamine derivative containing polyacrylamide gels that swell in response to a local 
decrease in pH uses this principle to detect glucose.56 Fluorescence based detection of 
hydrogel swelling has also been demonstrated using energy transfer between 
tetramethylrhodamine (TRITC) and AlexaFluor 647, co-immobilized in chitosan 
hydrogel microspheres.57 
 
2.3.2.2.2. Optical H2O2 transduction 
 Extremely low physiological H2O2 levels, allow H2O2 measurements with 
minimal background in biological samples.58 In this context, it is worth mentioning that 
all FDA approved CGMSs available in the market today rely on amperometric detection 
of H2O2 using electrodes. Fluorescence based enzymatic sensing that rely on H2O2 
fluctuations have also been developed, but are mostly irreversible and have been used as 
in vitro assays. For example, the conversion of non-fluorescent Amplex Red to 
fluorescent resorufin, was exploited to develop a glucose sensing assay; the H2O2 
produced via GOx mediated glucose catalysis, is converted to superoxide radicals in the 
presence of a montmorillonite clay coated electrode that in turn reacts with Amplex 
Red.59 Additionally, H2O2 sensitive quantum dots (QDs) and gold nanoclusters have 
been used to design irreversible sensing schemes. GOx conjugated to QDs (Mn-doped 
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zinc sulfide and CdTe) have been reported as glucose nanosensors.60, 61 Protein capped 
gold nanoclusters that are sensitive to H2O2 have also been used by a number of research 
groups to develop glucose sensing assays.62-64 Wolbeis et al. demonstrated the first and 
only reversible fluorescent H2O2 based enzymatic sensing. They reported a hydrogel 
based sensing system that contains GOx and europium tetracycline (EuTC); EuTC binds 
reversible to H2O2 with an increase in phosphorescence that is used for indirect glucose 
detection.65 
 
2.3.2.2.3. Optical transduction of oxygen 
 The most widely used method of indirect optical enzymatic sensing, utilizes 
oxygen sensitive fluorophores. The first report of such a sensor describes the use of an 
optical fiber coated with two layers: a GOx containing nylon membrane and decacyclene 
containing silicone layer.66 Using a blue excitation source, glucose could be easily 
detected in the range 0.1 – 20 mM with a response time of 1 – 6 min; the response time 
was further decreased by crosslinking GOx with glutaraldehyde.67 A fiber optic based 
flow injection analysis system capable of indirectly detecting glucose and lactate using 
oxygen sensitive decacyclene was also demonstrated.68 Although the use of decacyclene 
was very popular for almost a decade it was rapidly replaced by ruthenium complexes 
and metallo-porphyrins, owing to their large Stokes’ shift, high quantum yield, and long 
phosphorescence lifetimes. For the first time, ruthenium bipyridyl coupled to silica and 
immobilized in a GOx containing silicone matrix was demonstrated for use as an optical 
fiber based sensor.69 Similarly, other ruthenium complexes (e.g. ruthenium 
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phenanthroline, ruthenium di phenyl phenanthroline) in conjunction with oxido-
reducatase enzymes coated on optical fiber tips have also been used to develop 
sensors.70-72  This sensing scheme was successfully translated to fabricate implantable 
subcutaneous sensors; a dual sensor consisting of a glucose responsive unit and an 
oxygen reference was used to monitor physiological glucose levels (up to 20 mM).73, 74  
A few ruthenium based subcutaneous sensors have also been patented by companies 
including Becton Dickinson, Minimed Inc., and Baxter.75-77 Palladium and platinum 
porphyrins are another major class of oxygen sensitive probes that have been used in 
enzymatic sensing. These porphyrin dyes offer a better alternative than ruthenium probes 
because of their higher sensitivity to oxygen and longer excitation/emission 
wavelengths. Papkovsky demonstrated glucose sensing using optical fibers coated with 
GOx and platinum porphyrin containing polystyrene membrane; by monitoring changes 
in phosphorescence lifetime or intensity glucose was detected in the range 0.2 – 20 
mM.78 Bayer successfully patented a similar sensing system based on porphyrin dyes.79  
 
2.4. Oxygen indicators 
 Oxygen sensitive fluorophores are collisionally quenched in the presence of 
molecular oxygen. Quenching is usually represented by the Stern-Volmer equation: 
𝐼0
𝐼
=
𝜏0
𝜏
= 1 + 𝑘𝑞𝜏0[𝑄] = 1 + 𝐾𝑆𝑉[𝑄] 
Fluorescence/phosphorescence intensities in the absence and presence of oxygen are 
denoted by I0 and I respectively, whereas lifetimes in the absence and presence of 
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oxygen are represented by τ0 and τ respectively. Additionally, kq is the biomolecular 
quenching constant and Q is the concentration of oxygen. The product of kq and τ0 is 
typically denoted by a single variable Ksv, the Stern-Volmer quenching constant. The 
biomolecular quenching constant (kq) can be further described using the Smoluchowski 
equation as:  
𝑘𝑞 = 4𝜋𝑁𝑝(𝐷𝑓 + 𝐷𝑞)(𝑅𝑓 + 𝑅𝑞) × 10
−3 
In this equation, the diffusion coefficients of the fluorophore and the quencher (oxygen) 
are denoted by Df and Dq respectively, the collision radii of the fluorophore and the 
quencher (oxygen) are represented by Rf and Rq respectively, the Avogadro’s number by 
N, and the probability of collision by p. For a single dye-single quencher system all the 
variables described by the Smoluchowski equation remains constant with the exception 
of the diffusion coefficients, which are dependent on the dye immobilization technique 
used and the surrounding matrix.80 Diffusion coefficient variability warrants the 
empirical determination of KSV values for discrete dye-matrix combinations by 
measuring intensity or lifetime values with varying oxygen levels. A plot of 
intensity/lifetime against oxygen concentration is typically linear as describe by the 
Stern-Volmer equation; however, in reality there are cases where the relationship 
deviates from linearity. A Stern-Volmer plot with a downward curvature is due to 
unequal access of dye populations to the quencher whereas, an upward curved Stern-
Volmer plot results from a combination of static and dynamic quenching.80  
 Nonmetallic organic compounds and organometallic compounds have been used 
as luminescent oxygen sensitive probes. Nonmetallic organic compounds include 
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decacyclene compounds and polycyclic aromatic hydrocarbons (e.g. pyrene, quinolone); 
these compounds are characterized by short wavelength excitation and short decay 
lifetimes that leads to low signal-to-noise ratio and low oxygen sensitivity respectively, 
making them unsuitable for in vivo use.81 Organometallic compounds can be further 
classified as transition metal complexes and metalloporphyrins. Transition metal 
complexes or metal ligand complexes (MLCs) typically consists of a transition metal 
(e.g. ruthenium (II), Osmium (II), Iridium (III), rhenium (I)) complexed to one or 
multiple diamine ligands. The most commonly used ligands include 2, 2’–bipyridine and 
tris (4, 7–diphenyl–1, 10–phenanthroline). In these MLCs, electrons are transferred from 
metal orbitals to ligand orbitals when excitation photons are absorbed. This transfer 
takes place from a singlet to a triplet state via intersystem crossing, contributing to 
longer lifetimes when the excited complex state decays predominantly by non-radiative 
pathways. MLCs can have lifetimes ranging from 100 ns to 10 µs. When in the excited 
triplet state MLCs can be easily quenched by molecular oxygen with the formation of 
singlet oxygen. 
 Metalloporphyrins have similar electron transfer properties with longer lifetimes 
(100 µs to 1 ms) making them highly sensitive to oxygen. Porphyrins are naturally 
occurring macrocyclic compounds, containing four pyrrole rings connected by methine 
linkers; porphyrin rings coordinate with transition metal atoms to form 
metalloporphyrins. Pt- and Pd- porphyrins in particular have been widely popular for 
sensing oxygen due to their high quantum yield (~10–20%), high oxygen sensitivity, and 
long wavelength excitation / emission. The Pt- and Pd- porphyrins are a class of highly 
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stable metalloporphyrins, which can withstand extremes of temperature, pH, and salt 
concentrations while retaining their phosphorescent properties.82 Metalloporphyrins 
usually have three absorption peaks one around 400 nm (the Soret band) and two around 
500 – 650 nm (Q band) providing greater latitude while designing sensing schemes. In 
general, Pt- porphyrins are more sensitive as they have 10 times longer lifetimes than 
Pd- porphyrins; however, they have marginally shorter excitation / emission peaks 
making Pd- porphyrins more amenable for in vivo use. 
 
2.5. Mass transport limiting membranes 
 As explained previously, enzymatic sensors typically consist of oxidoreductase 
enzymes coupled to a transduction system, which can be either optical or 
electrochemical in nature. These transduction systems indirectly monitor analyte 
concentration by tracking changes in local oxygen, pH, or by-product (i.e. H2O2) levels. 
Enzymatic sensors require a delicate balance between the diffusion rates of both oxygen 
and analyte entering the sensor core and the enzymatic reaction kinetics. An ideal sensor 
is analyte-limited; the relative diffusion rate of analyte into the sensor is extremely low 
compared to that of oxygen. Under analyte-limited conditions the sensor response is 
linear, as the enzymatically consumed oxygen is rapidly replenished. However, as 
glucose levels continue to rise, oxygen concentration decreases to the point that it cannot 
be replenished anymore (oxygen-limited) and the sensor reaches saturation. Thus to 
maintain analyte-limited sensor behavior over a desired analyte range, a diffusion barrier 
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that regulates the relative diffusion rates of both oxygen and analyte is usually 
employed.83  
 For electrochemical sensors, control over the substrate fluxes has been achieved 
by using materials like Nafion 84 and silicone-based coatings. 85 However, application of 
these coatings is limited to relatively large surfaces because of the procedures required, 
such as casting and dip-coating. Alternatively, self-assembly coating techniques are 
useful for modifying smaller (micro or nano-scale) structures, which may be used as 
optical biosensors. 86-89 At these scales, the necessity to curb substrate diffusion becomes 
even greater as diffusion lengths are on the order of nanometers 90 and effective surface 
area relative to sensor volume is greatly increased.  
 Layer-by-layer (LbL) self-assembly is an attractive approach to address the 
analyte flux-control issue for these devices. Since Decher introduced the versatile LbL 
ultrathin film fabrication technique in the early 1990s,91 it has been used with a variety 
of polyelectrolytes and applied across many different fields. Among these, LbL-coated 
micro/nanoparticles and capsules enabled by the foundational work of Sukhorukov et al. 
92 have been explored intensively for various applications 93, 94 including biochemical 
sensing. 95, 96 The wide range of possible materials and conditions for LbL film 
fabrication allows fine-tuning of the resulting nanofilm properties. Despite this 
versatility and promise of tailorable features, the study and application of small-
molecule transport control with these LbL nanofilms has been limited to a few cases. 
Bruening systematically investigated the transport of small uncharged solutes like 
glucose across LbL polyelectrolyte multilayers (PEMs)97-99 using various 
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polyelectrolytes such as, poly (diallyldimethylammonium chloride) (PDADMAC), poly 
(sodium 4-styrenesulfonate) (PSS), poly (acrylic acid) (PAA) and poly (allylamine 
hydrochloride) (PAH). The findings from Bruening’s experiments suggested that 
glucose diffusion across PAH/PSS bilayers was orders of magnitude lower than 
PDADMAC/PSS bilayers. Moreover, Bruening also demonstrated that glucose diffusion 
could be further reduced by including PAA/PAH bilayers in the nanofilm architectures. 
The results also indicated that PSS-terminated bilayers are more effective in restricting 
glucose diffusion. 
 Despite these studies, none of the LbL designs have been able to finely-tune the 
movement of small molecules across LbL coated microcapsules; a capability that is 
desirable for various applications including biosensing, drug delivery, and anti-corrosive 
agent release. 
 
2.6. Hydrogels based sensors 
 The McShane group strives to overcome the limitations posed by metallic 
electrode based sensors by using fully implantable hydrogels. Roberts et al. 
demonstrated the use of biocompatible hydrogels containing immobilized sensing 
chemistry for potential use as fully implantable optical glucose sensors.29 This work 
established luminescence based indirect glucose sensing mediated by oxygen-sensitive 
(palladium (II) meso-tetra (4-carboxyphenyl) porphyrin) and pH-sensitive 
(seminaphtharhodafluor-4F 5-(and 6) - carboxylic acid)) fluorophores. Furthermore, the 
effect of biofouling on these sensors’ sensitivity and analytical range was also examined 
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in a later work; changes in diffusion characteristics and sensor response, when exposed 
to rat serum and after implantation in rats were thoroughly examined.100 Banking on 
these promising preliminary results, preclinical studies were performed by 
subcutaneously implanting red-light excitable hydrogel based sensors in pigs.101 
Although these sensors showed glucose response 2 h after implantation, they failed to 
register any response a week after implantation; this sensor failure can be attributed to 
depleting local oxygen levels over time. Based on this same sensing scheme, lactate 
sensors were also developed by Andrus et al.; however, these sensors also failed to 
operate at low oxygen.102  
  An alternative approach to fabricate functional hydrogel based devices involves 
embedding micro- or nano- sized spherical reactors within the hydrogel matrix. An 
introductory proof of concept study was conducted by Roberts et al.; microcapsules 
fabricated via LbL were used to develop composite hydrogels.103, 104 Building upon this 
work, Biswas et al. also demonstrated, the use of LbL nanocapsules containing oxygen-
sensitive porphyrin dye to construct oxygen sensing composite hydrogels.12 Enzyme 
containing spherical microdomains can be represented by a set of six equations that 
describe the reaction-diffusion kinetics using the standard partial differential equation:  
𝜕𝐶𝑖
𝜕𝑡
+ 
1
𝑟2
 
𝜕
𝜕𝑟 
(−𝐷𝑖  𝑟
2  
𝜕𝐶𝑖
𝜕𝑟
) =  𝑅𝑖  
where Di and Ri represent the diffusion coefficient and the reaction rates of one of the 
nine reaction species including analyte concentration, oxygen, enzyme concentration, 
hydrogen peroxide levels etc, r denotes the radius of the microdomains.105, 106 These 
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equations can be solved to predict the spatio-temporal distribution of the analytes and the 
products. As oxido-reductase enzymes act catalytically, the Thiele modulus (ɸ) 107-109 
given by  
ɸ𝑠 = √
𝑘𝑐𝑎𝑡[𝐸]
𝐷𝑠[𝑠]
𝑙 
is usually used to describe the reaction-diffusion balance of the system; where E is the 
concentration of enzyme (GOx, LOx), kcat is the catalytic turnover rate of  the enzyme, S 
is the concentration of the analyte (glucose or lactate), Ds is the diffusion coefficient, and 
l is the length of the reaction matrix. High Thiele modulus (ɸ) values (>1) are 
characteristic of diffusion limited systems, while values < 0.3 109-111 are indicative of 
reaction-limited systems. Furthermore, as these enzymatic reactions depend on the 
availability of oxygen, the Thiele modulus ratio ɸr : 
ɸ𝑟 = 
ɸ𝑜
ɸ𝑠
= √
𝐷𝑠[𝑠]
𝐷𝑜[𝑂]
 
between oxygen (ɸo) and the analyte (ɸs) in question allows a better understanding of 
the system; prior studies have shown that a ɸr value that lies between 2 and 100 is 
suitable for a sensor with desirable parameters (longer range with a high sensitivity).112  
 All prior works have failed to demonstrate the successful operation of a hydrogel 
based enzymatic sensor at physiologically lower oxygen levels. Subsequent chapters of 
this dissertation will describe the development and testing of nanocomposite hydrogel 
based enzymatic sensors that operate at low oxygen. 
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2.7. Multianalyte sensing and multifunctional composite devices 
 Several chronic conditions and metabolic disorders are characterized by 
fluctuations in multiple biomarkers; engendering an increased interest for the 
development of multianalyte sensors. 113, 114 Ideally a multianalyte sensor produces 
discrete signals characteristic to individual analytes with minimal interference. In case of 
optical sensors distinct signals can be achieved by using fluorescence reporters with non-
overlapping spectra or by using temporal lifetime separation techniques. Additionally, 
multiple optical transduction modes (e.g. luminescence intensity, luminescence lifetime, 
Raman scattering) can also be used for multianalyte detection, making signal separation 
easier.  Apart from multianalyte sensors, multifunctional composite sensing systems 
have also been gaining interest amongst researchers. A possible use of a multifunctional 
system aims to sense biomarkers and to release therapeutic agents simultaneously. These 
therapeutic agents may have a localized effect (e.g. reduce inflammation) to curb host 
response or a more systemic effect (e.g. regulate glucose by releasing insulin) that 
maintains body homeostasis.  Both, multianalyte and multifunctional systems have the 
potential to revolutionize chronic disease management; however, such hydrogel based 
sensing systems have not been studied. 
 
2.8. Summary 
 This work describes the development of composite hydrogel based enzymatic 
sensors that can continuously track relevant biomolecules (e.g. glucose, lactate). A 
stringent design requirement was to fine-tune the movement of analytes into bioactive 
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microreactors entrapped in hydrogel matrices, in order to make the sensor response 
diffusion limited. LbL deposited PAH/PSS bilayers were chosen as polymeric materials 
to coat the outer surface of the hollow microreactors; interlayer and interlayer 
crosslinking of PAH/PSS with glutaraldehyde was emphasized as a facile method to 
control analyte permeation rates. Further work was devoted to improving the sensor’s 
operational lifetime and response at low oxygen conditions by using solid alginate 
microspheres. Additionally, the modular nature of the composite hydrogel sensor was 
demonstrated by adapting the design to sense lactate at physiologically low oxygen 
levels. Subsequent sections study the limits of composite hydrogel based sensors for 
multianalyte and multiplexed sensing and the development of novel gold nanocluster 
based H2O2 microcapsule sensors for potentially monitoring enzymatic reactions in 
hydrogel sensors.  
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3. CROSS-LINKED NANOFILMS FOR TUNABLE PERMEABILITY CONTROL 
IN A COMPOSITE MICRODOMAIN SYSTEM * 
 
3.1. Introduction 
 Microcapsule technology plays a critical role in numerous applications for 
biotechnology, food, agriculture, cosmetic, and pharmaceutical industries.1-3 A capsule 
shell acts as a barrier between the payload material and the external microenvironment; 
functioning to modulate specific surface interactions and to selectively control 
permeability.4-6 An abundance of technology exists for the encapsulation of materials via 
entrapment, adsorption, or diffusional loading,7-12 where the preferred method for a 
given application is chosen based on the properties of the cargo being encapsulated and 
the desired function of the capsule. The interaction of the colloid-cargo composite with 
its environment may then be further modified by tuning the physical and the chemical 
properties of the capsule exterior. 
 Layer-by-layer (LbL) self-assembly provides a versatile route to modulate the 
surface properties of an assortment of template materials in a precise manner using a 
very simple process that may nevertheless result in a highly complex multifunctional 
coating.13 The deposition of these nanofilms is driven by a combination of chemical and 
physical interactions such as electrostatics, covalent bonding, hydrogen bonding, or  
 
 
* Reprinted with permission from “Cross-linked nanofilms for tunable permeability control in a composite 
microdomain system” by Biswas. A., Nagaraja. A.T., McShane. M.J. RSC Advances 2016, 6, 71781-
71790.  Copyright 2016 by The Royal Society of Chemistry. 
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bioaffinity;14 these may be adjusted by engineering the deposition conditions and the 
multilayer composition itself. Fortuitously, a large set of molecules are available for use 
in constructing these materials. The ability to achieve nanoscale architectural precision 
makes LbL uniquely suited to construct coatings that selectively control molecule 
permeation through the capsule wall for applications such as drug delivery,15 self-
healing smart coatings,16 or biosensing.17 The nanofilm coating can be used to match 
burst/sustained release profiles of active agents (drugs, anticorrosive substances) or to 
gate diffusion into the capsule interior for selective biomolecular sensing. For the special 
case of enzymatic bioreactors, the nanofilm coating can be used as a diffusion-limiting 
barrier for finely tuning substrate flux and hence substrate consumption. In enzymatic 
biosensors, this controls the reaction-kinetics of the sensor chemistry which manifests as 
changes in the sensor analytical range and sensitivity.18 
 LbL has been employed to make nanofilms for gas barrier coatings and 
separation membranes by the inclusion of high-aspect-ratio materials such as inorganic 
clay platelets (e.g. Laponite, vermiculite, or montmorrilonite) and graphene.19-22 These 
platelets are assembled to align parallel to each other within the nanofilm layers (normal 
to the direction of analyte flux) to create a highly tortuous path for molecules diffusing 
through the layers. However, the use of platelet LbL to regulate molecular permeation 
rates has been more effective on planar films than on colloidal templates. There have 
been a few examples of capsules fabricated with platelet-based nanofilm layers23-26 but 
the reduction in observed diffusion was substantially lower compared to the planar 
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equivalent. An innovative approach to reduce permeability of capsule walls involves the 
introduction of preformed nanoparticles or in situ nucleation and growth of nanoparticles 
within the polymer shell.27-29 These methods produce structurally stable microcapsules 
with stimuli responsive burst release capabilities; however, they still face a challenge in 
achieving reproducible and controlled reduction of permeability.27  
 In addition to the compositional route, permeability through soft material 
nanofilms may also be controlled by changing the number of layers or the thickness and 
structure of these layers using different deposition conditions. Electrostatic deposition of 
polyelectrolytes can be controlled with a high degree of reproducibility and precision by 
controlling pH and salt concentration.30-32 These methods have been shown to be 
effective on planar films33, 34 but face challenges for replication in capsule formation due 
to tedious process flow and quality control issues ascribed to colloidal destabilization.35  
UV, thermal, or chemical cross-linking of polyelectrolyte multilayer (PEM) films have 
also been demonstrated as an effective means to affect film permeability while also 
varying structural properties. UV cross-linked diazoresin / poly (styrene sulfonate) 
microcapsules that are extremely stable to solvents and osmotic pressure fluctuations, 
have exhibited reduced permeability to enzymes.36, 37 Carbodiimide-activated or 
thermally-induced cross-linking between amine and carboxylic acid groups present in 
PEMs have also been reported to produce capsules with enhanced physical stability and 
decreased permeability.38-41 Another promising approach to fabricate high diffusion 
barrier nanofilms is to cross-link amine containing polyelectrolytes using 
glutaraldehyde. Grunlan’s group reported that glutaraldehyde cross-linking of an amine-
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containing polyelectrolyte polyethylenimine (PEI) could reduce the diffusion of oxygen 
across planar nanofilms below detection limits.42, 43 It has been established that 
glutaraldehyde cross-linked planar nanofilms can limit the diffusion of monovalent and 
divalent cations;44 glutaraldehyde cross-linked polymeric microcapsules have also been 
shown to possess better chemical, thermal, and mechanical stability, with reduced 
permeability to larger macromolecules (460 - 2000 kDa FITC - Dextran) compared to 
non-cross-linked microcapsules made from similar amine-containing PEMs.45-47  
 Although there has been considerable progress in LbL technology to forge 
capsules with enhanced stability and stimuli-sensitive switchable permeability 
characteristics,48, 49 advancement related to finely tuning diffusion of analytes in/out of 
polymeric capsules has been scarce and limited to methods involving irreversible 
enzymatic degradation of the microcapsule shell.50, 51 This is somewhat surprising given 
that capsule permeability control is especially vital in payload release and biosensing 
applications that demand precise diffusion control to achieve desired functionality.17, 52  
  In this study we explored the use of glutaraldehyde cross-linked PAH [poly (allylamine 
hydrochloride)] / PSS [poly (sodium 4-styrenesulfonate)] bilayers to provide accurate 
and reproducible control over the diffusion of a model analyte glucose. The controlled 
reduction in glucose permeation rate is examined by varying the number of cross-linked 
PAH/PSS bilayers deposited on planar Anopore membranes. The cross-linked nanofilm 
constructs were translated onto sacrificial calcium carbonate templates to construct 
microcapsule-based enzymatic reactors for glucose oxidation, which were also 
functionalized with a phosphor for optical readout.  These micron-sized glucose sensors 
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were ultimately dispersed in an alginate hydrogel matrix. Flux-based enzymatic 
microcapsule sensors immobilized in a matrix act in an ensemble fashion, thus any 
change to substrate permeation properties of individual microcapsules manifests as 
substantial shifts in bulk sensor properties. This provides a powerful tool to probe 
substrate diffusion across the microcapsule wall towards the engineering of a tunable 
biosensing hydrogel device, which may be used as a fully implantable soft-material 
enzymatic sensor to monitor physiologically relevant biomarkers. 
 
3.2. Experimental section 
3.2.1. Chemicals  
 Sodium carbonate (Na2CO3), calcium chloride (CaCl2), poly (sodium 4-
styrenesulfonate) (PSS, average Mw 70000 Da), poly (diallyldimethylammonium 
chloride) (PDADMAC, average Mw 100000-200000 Da), poly(allylamine 
hydrochloride) (PAH, average Mw 15000 Da), glutaraldehyde solution (grade II, 25% in 
H2O), alginic acid sodium salt from brown algae (100-300 cP, 2% at 25 °C), and buffer 
salts (NaHCO3, MES, C2H3NaO2, and TRIS) were obtained from Sigma and were used 
as received without further purification. Glucose oxidase (GOx) from Aspergillus niger 
(257 U/mg, BBI solutions) and Pd-meso-tetra (4-carboxyphenyl) porphine (PdTCPP, 
Frontier Scientific) suspended in DMSO (10 mM) solution were used in all experiments. 
Glucose used for all sensor response studies was obtained from Macron Fine Chemicals. 
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3.2.2. Layer-by-layer assembly on planar substrate  
 Nanofilms were deposited on Whatman Anopore inorganic aluminum oxide 
membrane filters (25 mm diameter, 0.02 μm pore size) placed in an open-face filter 
holder (Pall Co.). The open face of the filter membrane was exposed to oppositely 
charged polyelectrolyte solutions 20 mg/mL PDADMAC (pH 8), 20 mg/mL PAH (pH 
8), 20 mg/mL PSS (pH 7.2) alternately with wash steps (5 mM NaHCO3) between each 
polyelectrolyte exposure step. A primer coating consisting of [PSS]-[PDADMAC/PSS]5 
was deposited to achieve complete surface coverage53 before depositing the desired 
number of PAH/PSS bilayers (Figure 1A). After depositing the target number of 
PAH/PSS bilayers, the nanofilms were exposed to 0.1 M glutaraldehyde solution for 30 
minutes to cross-link the amine groups on PAH (Figure 5A). Excess glutaraldehyde was 
removed by washing the nanofilms with 5 mM NaHCO3 (pH 7.2). All polyelectrolyte 
solutions were prepared in 5 mM NaHCO3.  
 To fabricate interspersed cross-linked PAH layers (Figure 1B), a 
PSS/PDADMAC layer was deposited between successive PAH/PSS bilayers. Cross-
linking of the interspersed layers was performed using the same protocol to cross-link 
non-interspersed PAH/PSS bilayers. It should be noted that when depositing PAH/PSS 
bilayers wash steps were performed using 5 mM NaHCO3 (pH 7.2), and while depositing 
PDADMAC/PSS bilayers 5 mM NaHCO3 (pH 8) was used for the washing steps, to 
ensure that the polyelectrolytes were sufficiently ionized while deposition. 
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Figure 1. (A) [PAH/PSS]n nanofilms and the primer coating ([PSS]-[PDADMAC/PSS]5) 
deposited on Anopore membrane, (B) [PSS/PAH/PSS/PDADMAC]n-1-[PAH/PSS] 
nanofilms and the primer coating ([PSS]-[PDADMAC/PSS]5) deposited on Anopore 
membrane. 
 
 
3.2.3. Permeability measurements 
 Nanofilms fabricated on Anopore membrane filters, were placed between the 
feed and the permeate chambers of a side-by-side diffusion cell (Permegear Inc.). The 
feed chamber was filled with 7 mL of 5 mM NaHCO3 (pH 7.2) containing 1 g/L glucose 
and the permeate chamber was filled with 7 mL of 5 mM NaHCO3 (pH 7.2). Samples 
were collected from both the feed and the permeate sides at regular time intervals, and 
the glucose concentration of the samples were measured using a YSI biochemistry 
analyzer (2700 Select). The rate of increase in concentration over time in the permeate 
chamber (dC/dt) was calculated by linear regression for the different nanofilm 
formulations. 
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3.2.4. Nanofilm coated microparticles with encapsulated sensing chemistry 
 PdTCPP and GOx containing calcium carbonate (CaCO3) microparticles were 
synthesized using the co-precipitation method, 115 with minor modifications. Briefly, 200 
µL of 10 mM PdTCPP solution was added to 8 mL of 0.2 M Na2CO3 containing 64 mg 
of GOx under continuous stirring (800 RPM). After 5 mins, 8 mL of 0.2 M CaCl2 was 
added rapidly and the reaction was allowed to continue for 10 mins. Nanofilms were 
deposited on the PdTCPP and GOx containing microparticles, by alternately exposing 
the particles to polyelectrolyte solutions (20 mg/mL PDADMAC (pH 8), 20 mg/mL 
PAH (pH 8), 20 mg/mL PSS (pH 7.2)) with intermediate wash steps. The wash solutions 
used were the same as describe above for making nanofilms on planar substrates. After 
depositing the desired number of nanofilms, 3.3 mg of nanofilm-coated microparticles 
was suspended in 10 mL, 3 M glutaraldehyde solution for 30 min. Excess glutaraldehyde 
was removed by washing the microparticles with 5 mM NaHCO3 (pH 7.2). The amount 
of glutaraldehyde used for the microcapsules was based on the ratio of [nanofilm surface 
area]:[mass of glutaraldehyde]. Hollow microcapsules were made from the PEM lined, 
payload containing microparticles, by exposing them to 0.2 M sodium acetate buffer at 
pH 5.1. 
 
3.2.5. Microporous alginate composite (MPAC) hydrogels 
 MPAC hydrogels were made using a modified version of the protocol described 
by Roberts et al.55 Briefly, microcapsules fabricated using 3.3 mg of PEM coated CaCO3 
microparticles were suspended in 75 µL of deionized water, non-coated CaCO3 
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microparticles (25 µL of 33.3 mg/mL), 3% alginate solution (200 µL), and MES (100 
µL, 0.5 M, pH 6.1) were mixed to make a slow-gelling hydrogel precursor. The 
precursor was then poured between two glass slides separated by a 1.5 mm Teflon 
spacer, and allowed to gel for 24 hours.  
 
3.2.6. Characterization 
 Confocal fluorescence and differential interference contrast (DIC) microscopy 
images were captured using an inverted laser spinning-disk confocal microscope 
(Olympus IX81, Yokogawa CSU-X1). Hydrogel samples excited at 488 nm were viewed 
through 40 X and 100 X oil immersion objectives. Images were analyzed using ImageJ 
1.48 v software. 
 SEM images of nanofilm coated microparticles, microcapsules and MPAC 
hydrogels were captured using a JEOL 7500 scanning electron microscope. A diluted 
sample of either nanofilm coated microparticles or microcapsules was placed on a silica 
wafer and was allowed to dry overnight. To prepare a hydrogel sample for SEM 
imaging, a 5 mm X 5 mm hydrogel was placed on a silica wafer and dried overnight. All 
samples were sputter-coated with 2.5 nm of palladium/platinum before imaging. SEM 
images were analyzed using ImageJ 1.48 v software. 
 
3.2.7. Sensor response testing 
  Hydrogel discs (4 mm radius) were excised from the hydrogel slab using a 
biopsy punch. Each sample was placed in a liquid flow cell (Figure 2), and changes in 
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lifetime with varied glucose and oxygen concentrations were recorded using a custom 
time-domain lifetime measurement system as described elsewhere.56  
The response to oxygen was evaluated by flowing buffer having varied dissolved oxygen 
concentrations (0 - 206.8 µM). The dissolved oxygen concentration of 10 mM TRIS (pH 
7.2) containing 10 mM CaCl2 was changed by purging air and nitrogen with mass flow 
controllers (type 1179A, MKS). 
 To determine the response to glucose, solutions containing different 
concentrations of glucose (0 - 400 mg/dL) dissolved in 10 mM TRIS (pH 7.2) with 10 
mM CaCl2 were flowed over the hydrogel samples. The response parameters were 
calculated from each of the obtained response curves. The limit of detection (LOD) was 
estimated by calculating the glucose concentration at which the response was 10 % 
higher than the response at 0 mg/dL glucose concentration. Similarly, the maximum 
differentiable glucose concentration (MDGC) was estimated by calculating the glucose 
concentration at which the response was 10% lower than response at 400 mg/dL glucose 
concentration. The range of the sensor was defined as R = MDGC-LOD, while the 
sensitivity was defined as the percent change in the maximum and minimum response 
observed per unit range of the sensor.  
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Figure 2. Schematic diagram of (A) enzyme/dye containing microdomain bound by 
nanofilm coating, (B) a section of the microdomain containing hydrogel and (C) the 
experimental setup consisting of the flow through cell and the time-domain lifetime 
measurement system used to evaluate sensor response. 
 
 
 In order to test the long term stability of MPACs, MPACs containing cross-
linked [PDADMAC/PSS]5-[PAH/PSS]9 bound microdomains were continuously 
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exposed to 400 mg/dL glucose and lifetime of the sensors were measured every 5 min. 
With increase in glucose, the baseline lifetime (~133 µs) of the sensors rose and 
achieved steady state; this steady state lifetime (~310 µs) is considered to be 100% 
signal retention and subsequent drop in lifetime is reported with respect to this value. 
 
3.3. Results and discussion 
3.3.1. Permeation studies on planar nanofilm 
 The effect of glutaraldehyde cross-linking of PAH/PSS bilayers on the diffusion 
of glucose was evaluated by measuring the rate of glucose diffusion across PAH/PSS 
nanofilm constructs deposited on Anopore membranes. PAH/PSS bilayers were 
deposited on the primer coating (PSS-[PDADMAC/PSS]5) to fabricate PSS-
[PDADMAC/PSS]5-[PAH/PSS]n multilayers, where n was varied from 1 to 10. The 
glucose diffusion across different nanofilm formulations was evaluated by calculating 
the linear slope of the glucose concentration change dC/dt (where C is the concentration 
of glucose (g/L) and t is time (hours)) on the permeate side of the diffusion cell. The data 
presented in Figure 3 shows the decrease in dC/dt for both the cross-linked and non-
cross-linked PAH/PSS bilayers as the number of layers is increased. It is quite clear that 
the decrease in dC/dt is much more pronounced in the case of the cross-linked PAH/PSS 
bilayers. Specifically, the glucose permeation rate through non-cross-linked PAH/PSS 
bilayers decreases by ~ 46 % when n is increased from 3 to 9, whereas the dC/dt of 
cross-linked PAH/PSS bilayers decreases by ~ 98% for the same number of bilayers. It 
is evident from this that the cross-linked films more effectively prohibit the free 
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diffusion of glucose compared to the native nanofilm constructs. For the same number of 
bilayers, cross-linking significantly decreases the dC/dt across the multilayer constructs. 
Comparing the glucose permeation rates through cross-linked and non-cross-linked 
PEMs when n = 3, 5, and 9, the dC/dt of glucose through the cross-linked PEMs was 
found to be less than the corresponding non-cross-linked PEMs by ~ 71%, ~ 88% and ~ 
99%, respectively. Extrapolating fitted data (Figure 4), revealed that 124 non-cross-
linked PAH/PSS bilayers would be required to achieve the glucose permeation rate 
obtained when using 9 bilayers of cross-linked PAH/PSS. The first five cross-linked 
bilayers decrease the glucose permeation rate drastically; however, further increase in 
the number of cross-linked bilayers has a proportionally lower effect. The dC/dt values 
for glucose through the cross-linked PEMs change by ~ 39% when comparing diffusion 
rates between n = 1 and n = 2, whereas the decrease was only ~ 15% when comparing n 
= 5 and n = 6. This is believed to simply be a function of the percentage of total film 
thickness represented by the additional layers; in the first case, doubling the thickness of 
cross-linked layers is a more substantial increase in thickness than adding one layer to 
five already deposited (15-20% increase). 
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Figure 3. The glucose permeation rate (dC/dt) through PAH/PSS bilayers composed of 
cross-linked PSS-[PDADMAC/PSS]5-[PAH/PSS]n (blue ◊), cross-linked PSS-
[PDADMAC/PSS]5-[PSS/PAH/PSS/PDADMAC]n-1-[PAH/PSS] (green □), non-cross-
linked PSS-[PDADMAC/PSS]5-[PAH/PSS]n (red ○), and the primer coating PSS-
[PDADMAC/PSS]5 where n = 0 (purple Δ). Error bars represent 95% confidence intervals 
for three separate nanofilm constructs.  
 
 
 
 
Figure 4. The glucose permeation rate (dC/dt) through PAH/PSS bilayers composed of 
non-cross-linked PSS-[PDADMAC/PSS]5-[PAH/PSS]n  (red ○). Error bars represent 95% 
confidence intervals for three separate nanofilm constructs. 
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Figure 5. (A) Cross-linking of poly (allylamine hydrochloride) (PAH) by glutaraldehyde. 
(B) Glutaraldehyde cross-linked PAH/PSS nanofilm constructed without and with a 
PDADMAC/PSS spacer bilayer. 
 
 
 The drastic decrease in permeability to glucose when the –NH2 groups of the 
PAH layer are cross-linked (Figure 5A) in the presence of glutaraldehyde may be 
attributed to the decrease in free volume present in the PEMs.42, 43 Apart from cross-
linking the –NH2 groups of PAH in an individual PAH layer, the possibility also exists 
to have cross-linked –NH2 groups present in successive PAH layers due to the 
interpenetrating nature of LbL assembled PEMs.57 This led us to question the extent of 
interlayer and intralayer cross-linking and the corresponding influence on glucose 
diffusion. To investigate this, nanofilms were designed with a spacer bilayer 
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PSS/PDADMAC introduced between successive PAH/PSS bilayers (Figure 5B). The 
spacer containing PEMs fabricated are represented by PSS-[PDADMAC/PSS]5-
[PSS/PAH/PSS/PDADMAC]n-1-[PAH/PSS]. The spacer containing cross-linked 
PAH/PSS bilayers were found to limit glucose diffusion to a greater extent than non-
cross-linked nanofilms but less than cross-linked PAH/PSS nanofilms without spacer 
bilayers (Figure 1). Introduction of the PSS/PDADMAC spacer bilayer allowed glucose 
to diffuse through the nanofilm coatings more freely as compared to glucose diffusion 
across non-spacer containing successively cross-linked films with the same total number 
of PAH layers. For n = 3, 5, and 9 the dC/dt of cross-linked P PSS-[PDADMAC/PSS]5-
[PSS/PAH/PSS/PDADMAC]n-1-[PAH/PSS] was 2.5, 4.5, and 81 times greater, 
respectively, than their cross-linked counterparts without the spacers (PSS-
[PDADMAC/PSS]5-[PAH/PSS]n). It is important to recognize that the metrics used are 
of glucose permeation rate and are not normalized by film thickness. Thus, even though 
the cross-linked spacer-containing PEMs contain more layers and are overall thicker, the 
total glucose diffusion barrier is less than the cross-linked PEMs without the spacer 
bilayers. This increase in dC/dt is ascribed to the reduced interlayer cross-linking by the 
introduced spacer bilayer that decreases the interpenetration of neighboring PAH layers.  
Once the glucose permeation rate effects were determined with the planar multilayers, 
the nanofilm architectures were translated to microparticle template coatings as a way to 
fabricate microcapsule based optical glucose sensors. The expectation was that the 
varying glucose permeation rate of the different nanofilms would result in 
correspondingly shifted glucose sensor behavior (sensitivity and response range). In 
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these enzymatic glucose sensors, GOx catalyzes the oxidation of glucose in the presence 
of molecular oxygen, ultimately producing gluconic acid (glucose + O2 + glucose 
oxidase + H2O  →  gluconic acid + H2O2). If the enzyme is in excess, and the reaction is 
not limited by oxygen supply then the decrease in molecular oxygen should be 
proportional to the amount of glucose oxidized. Thus measuring the decrease in 
molecular oxygen using an oxygen sensitive phosphorescent dye (PdTCPP) enables the 
indirect measurement of glucose concentrations. The design described, places severe 
demands on transport control. In a generic enzymatic biosensor, a diffusion-limiting 
coating is used to restrict the amount of substrate entering the enzyme module per unit 
time, effectively making the system substrate-transport limited rather than reaction-
kinetics limited.58 It is important to appreciate that the overall range and the sensitivity 
of an enzymatic biosensor can be tailored by controlling the rate of substrate diffusion.59 
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Figure 6. SEM images of sputter-coated (A) cross-linked [PDADMAC/PSS]5-
[PAH/PSS]9 coated microparticle (B) cross-linked [PDADMAC/PSS]5-[PAH/PSS]9 
bound microcapsule (C) MPAC containing cross-linked [PDADMAC/PSS]5-[PAH/PSS]9 
bound microdomains. Scale bars correspond to 1 µm. 
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Figure 7. Energy Dispersive X-ray Spectroscopy (EDS) spectra for sputter coated (4nm 
of palladium/platinum) cross-linked [PDADMAC/PSS]5-[PAH/PSS]9 microcapsule 
samples, prepared on silicon substrates. Absence of calcium in the spectra confirms 
complete dissolution of CaCO3.  Platinum, palladium, and silicon peaks result from the 
silicon substrate and the sputter-coated film. 
 
 
3.3.2. Characterization of nanofilm coated microparticles, microcapsules, and 
nanocomposite hydrogels 
 The cargo containing microparticles and capsules were first characterized by 
optical and electron microscopy to confirm that the desired products were produced in 
the fabrication process. SEM images of cross-linked [PDADMAC/PSS]5-[PAH/PSS]9 
coated microparticles (Figure 6A) revealed the spherical morphology of the CaCO3 
microparticles bound by fuzzy PEMs. The average diameter of the coated particles is 
estimated to be about 3.6 µm. Elemental analysis carried out using an EDS system 
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attached to the SEM (Figure 7) confirmed that CaCO3 was no longer present in the 
microcapsules after dissolution of the CaCO3 core. The hollow microcapsules (Figure 
6B) appear as collapsed structures, which occurs when specimens are dried during 
sample preparation for SEM. The SEM image of the cross-linked PAH/PSS coated 
microparticles are similar to those reported by Volodkin et al.3 However, the cross-
linked PAH/PSS microcapsules appear to have capsule walls that collapse less than the 
cross-linked PAH/PSS microcapsules fabricated by Tong et al.45 and Wang et al.47 This 
minor difference is attributed to the greater number of cross-linked bilayers and increase 
in overall coverage by the PAH/PSS bilayers compared to prior studies. Images of the 
microcapsules entrapped in MPAC hydrogels (Figure 6C) reveal a wrinkled 
microporated morphology for the hydrogel when dried, which is characteristic of 
microcapsule-containing MPAC gels.55 
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Figure 8. DIC images of MPAC hydrogels containing cross-linked microcapsules 
([PDADMAC/PSS]5-[PAH/PSS]9) at (A) 40 X magnification and (C) 100 X 
magnification. Fluorescence microscopy images of microcapsule containing MPAC gels 
at (B) 40 X magnification, (D) 100 X magnification (ambient oxygen), (E) 100 X 
magnification (reduced oxygen) and the intensity ratio of the MPACs under reduced 
oxygen to ambient oxygen (F). Scale bars correspond to 10 µm. Color coded scale 
corresponds to intensity ratios of PdTCPP containing microdomains (reduced oxygen : 
ambient oxygen). 
 
 
 Differential interference contrast (DIC) micrographs (Figure 8A and Figure 8C) 
revealed that the cross-linked microcapsules containing GOx and PdTCPP were 
uniformly distributed when immobilized in MPAC hydrogels. The average diameter of 
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the microcapsules entangled in the MPAC gels was estimated using ImageJ software to 
be 4.0 ± 0.4 µm, which is comparable to the size of the corresponding nanofilm-coated 
microparticle templates viewed by SEM. The slightly larger estimated size of the 
microcapsules viewed by DIC images may be attributed to the hydrated state of the 
samples relative to the dried samples used for SEM. In the confocal micrographs (Figure 
8B and Figure 8D) the phosphorescent dye PdTCPP is clearly localized in the spherical 
microdomains, which is expected as the dye is confined within the nanofilm boundary. 
The MPAC hydrogels were imaged under ambient (Figure 8D) and reduced oxygen 
(Figure 8E) conditions, while keeping the camera settings constant to obtain a ratio 
image (Figure 8F). An intensity ratio (reduced oxygen : ambient oxygen) corresponding 
to > 1 depicts that the PdTCPP intensity has increased under reduced oxygen. While not 
absolutely quantitative, these images show that the dye remains localized within the 
capsules and retains its response to oxygen after glutaraldehyde cross-linking and 
immobilization in the hydrogel. 
 Alginate matrices containing GOx/PdTCPP microdomains can potentially 
function as enzymatic biosensors. GOx contained in these microdomains oxidizes 
glucose, reducing local oxygen concentrations proportional to the glucose permeation 
rate. We envisioned to tune the analytical range and sensitivity of the hydrogel based 
sensor by decreasing glucose permeation rate into the microdomains, eventually making 
it a truly glucose-diffusion limited system. However, it is imperative to understand that 
glucose-limited behavior is achieved only if the influx of oxygen is much higher than or 
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equivalent to the influx of glucose; requiring the nanofilms to preferentially decrease 
glucose diffusion rates over oxygen diffusion rates.  
 The response of the MPAC hydrogels containing PdTCPP and GOx loaded 
microdomains to changing oxygen concentrations was evaluated to ascertain whether 
cross-linking of PAH/PSS bilayers affects oxygen diffusion. As a control, the oxygen 
sensor response of MPAC hydrogels containing non-cross-linked [PDADMAC/PSS]5-
[PAH/PSS]9 microcapsules was also determined. Figure 9 (inset) represents the Stern-
Volmer normalized lifetime (lifetime at zero oxygen concentration divided by lifetime at 
given oxygen level) against varying oxygen concentrations. KSV values were calculated 
using the Stern-Volmer equation τ0/τ = 1+KSV [O2], and found to be 0.030 ± 0.002 µM-1 
on an average. All the hydrogel samples having different nanofilm compositions showed 
a high sensitivity to oxygen at levels less than 100 µM, and a decreased sensitivity at 
higher oxygen concentrations, characteristic of oxygen-sensitive palladium porphyrin 
dyes.60-62 The similar oxygen response characteristics show that cross-linking of the 
nanofilms in the hydrogel does not affect the kinetics of oxygen diffusion. 
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Figure 9. Quenching curves. Lifetime and (Inset) normalized lifetime (normalized to the 
lifetime at zero oxygen concentration) against varying oxygen concentrations for MPAC 
hydrogels containing microdomains bound by different nanofilm architectures. The cross-
linked nanofilm architectures are represented by [PDADMAC/PSS]5-[PAH/PSS]n where 
n = 3 (red □) , n = 5 (purple Δ), n = 7 (green ○), n = 9 (blue ◊) and non-cross-linked 
nanofilm architecture [PDADMAC/PSS]5-[PAH/PSS]9 ( black ×). Error bars represent 
95% confidence intervals for three separate MPAC hydrogels. The dashed lines are 
provided only as a guide to the eyes. 
 
 
3.3.3. Sensor response of hydrogels 
 The glucose sensing characteristics of MPACs containing non-cross-linked 
[PDADMAC/PSS]5-[PAH/PSS]n nanofilm bounded microdomains were examined to 
establish that cross-linking of PAH/PSS bilayers was necessary to alter the sensor 
characteristics significantly. The phosphorescence lifetime of MPAC hydrogels 
containing PdTCPP and GOx loaded microdomains was recorded as the materials were 
exposed to buffer solutions containing varied concentrations of glucose (0 - 400 mg/dL). 
The normalized sensor response curves for MPACs containing non-cross-linked 
 49 
 
[PDADMAC/PSS]5-[PAH/PSS]n nanofilm bounded microdomains are illustrated in 
Figure 10A, where the change in lifetime is calculated relative to the lifetime obtained at 
maximum glucose concentration (refer to Figure 10C for non-normalized lifetime 
response curves). A coherent trend was observed in terms of sensitivity and range of the 
sensors as the number of bilayers was increased. This was anticipated since altering the 
transport properties of the microcapsule directly influences the sensor characteristics.63  
With an increase in the number of PAH/PSS bilayers from n = 3 to n = 9, the analytical 
range increases by ~ 106% while the sensitivity over the same range decreases by ~ 
59%. This inverse relationship between range and sensitivity is characteristic of flux-
based sensors.59 Table 1 summarizes the sensor parameters for non-cross-linked 
microcapsule-containing hydrogels. The decrease in the flux of glucose diffusing into 
the microdomains as the number of bilayers are increased accounts for the changed 
sensor response characteristics. Although the analytical range increases as the number of 
bilayers are increased, the analytical range achieved for the materials using non-cross-
linked nanofilms still does not encompass the usual operational range for glucose 
sensors (0 - 400 mg/mL).64 All of the sensor formulations made using non-cross-linked 
PEMs were highly sensitive to glucose changes in the hypoglycemic range (< 70 
mg/dL),65 but they failed to detect glucose concentration changes above 98 mg/dL. This 
suggests that the glucose flux into the microdomains is too high, which either 
overwhelms the enzyme or consumes oxygen too fast. These findings indicate that the 
diffusion of glucose into the discrete microdomain sensors should be decreased further, 
to make the composite hydrogel system glucose-diffusion limited.  
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Figure 10. (A) Sensor response curves of MPACS containing non-cross-linked 
[PDADMAC/PSS]5-[PAH/PSS]n nanofilm bounded microdomains when n = 3 (red □), n 
= 5 (purple Δ), n = 7 (green ○) or n = 9 (blue ◊). (B) Sensor response curves of MPACs 
containing cross-linked [PDADMAC/PSS]5-[PAH/PSS]n nanofilm bounded 
microdomains when n = 3 ( red □ ) , n = 5 ( purple Δ ), n = 7 ( green ○ ) or n = 9 ( blue ◊ 
). Error bars represent 95% confidence intervals for three separate MPAC hydrogels. The 
dashed lines are provided only as a guide to the eyes.  
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Table 1. Calculated sensor parameters for MPACs containing non-cross-linked and 
cross-linked [PDADMAC/PSS]5-[PAH/PSS]n nanofilm-bounded microdomains a 
 
 
LOD b 
(mg/dL) 
MDGC c 
(mg/dL) 
Range d 
(mg/dL) 
Sensitivity/ran
ge (% per 
mg/dL) 
Non-cross-linked     
[PAH/PSS]3 12.0 ± 6.8 54.4 ± 3.2 40.7 ± 8.8 13.0 ± 4.5 
[PAH/PSS]5 15.6 ± 0.1 54.6 ± 4.9 39.8 ± 4.5 13.2 ± 0.6 
[PAH/PSS]7 11.5 ± 2.3 62.5 ± 2.1 51.0 ± 4.3 9.4 ± 1.6 
[PAH/PSS]9 14.4 ± 2.0 98.2 ± 7.4 83.8 ± 5.5 5.3 ± 0.5 
Cross-linked     
[PAH/PSS]3 14.3 ± 5.0 65.4 ± 7.3 52.2 ± 11.1 12.5 ± 3.4 
[PAH/PSS]5 24.3 ± 4.8 170.8 ± 23.4 168.0 ± 13.4 2.0 ± 0.4 
[PAH/PSS]7 32.9 ± 3.7 296.4 ± 28.9 271.4 ± 23.0 0.9 ± 0.1 
[PAH/PSS]9 33.2 ± 9.7 321.2 ± 8.2 292.7 ± 9.5 0.8 ± 0.1 
 
a In each case, data from three separate MPAC hydrogels were used to calculate mean 
values (95% confidence). bLOD, limit of detection; cMDGC, maximum differentiable 
glucose concentration; dRange, MDGC-LOD.  
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 Having demonstrated that non-cross-linked nanofilm containing sensor 
formulations are not effective in controlling sensor dynamics considerably, the sensor 
response of formulations containing glutaraldehyde cross-linked microdomains were 
evaluated (refer to Figure 10D for non-normalized response curves). As expected, with 
an increase in the number of cross-linked PAH/PSS bilayers in the nanocomposite 
hydrogels, the analytical range of the sensors increases and the sensitivity decreases 
(Figure 10B). The analytical range increases by ~ 461% while the sensitivity over the 
range decreases by ~ 94%, as n is increased from 3 to 9. The analytical range and 
sensitivity of MPAC hydrogels containing cross-linked [PDADMAC/PSS]5-[PAH/PSS]9 
was found to be ~ 227% more and ~ 85% less respectively than MPAC hydrogels 
containing non-cross-linked [PDADMAC/PSS]5-[PAH/PSS]9. Thus, cross-linking of 
PAH/PSS bilayers is crucial to significantly decrease dC/dt of glucose into the sensor 
and alter sensor response parameters considerably. However, as discussed previously, 
the rate of change of dC/dt decreases with the increase in the number of cross-linked 
bilayers that consequently affects how the sensor characteristics change as number of 
bilayers are increased. The analytic range increases by ~ 8% and the sensitivity over the 
range decreases by ~ 8% when the number of cross-linked bilayers is increased from 7 to 
9. This change is insignificant compared to the change in response between sensors 
fabricated from 3 cross-linked bilayers and 5 cross-linked bilayers. Sensor figures of 
merit for cross-linked microcapsule-containing hydrogels are summarized in Table 1. 
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Figure 11. Plot depicting decrease in lifetime signal of MPACs containing cross-linked 
[PDADMAC/PSS]5-[PAH/PSS]9 nanofilm bounded microdomains when continuously 
exposed to 400 mg/dL glucose. Error bars represent 95% confidence intervals for three 
separate MPAC hydrogels. 
  
 
 Finally, to examine the long term stability of the glucose sensors, the hydrogels 
were continuously exposed to 400 mg/dL glucose; at 400 mg/dL glucose, the sensor 
response is completely saturated because GOx converts glucose at the maximum rate 
possible. This simulates an extreme scenario when a sensor is exposed to very high 
levels of glucose. The signal retention of the sensor gradually decreased (Figure 11) over 
time (~ 50% loss in 48 h) indicating loss in GOx activity. As GOx becomes less active it 
loses its ability to oxidize glucose resulting in less consumption of local oxygen that is 
manifested as loss in sensor response. This result prompted the search for alternative 
GOx immobilization techniques (discussed in the next section) in order to improve the 
sensors operational lifetime. 
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3.4. Conclusion 
 This work demonstrates the utility of glutaraldehyde cross-linked LbL nanofilms 
for precise diffusion control and the application of this technology for the development 
of glucose sensors. The diffusion control of cross-linked films was first investigated 
using planar films to develop a method capable of providing a large diffusion barrier, 
while also considering the design constraints needed for eventual use in engineering 
microcapsules. Cross-linking just a few bilayers of nanofilms reduced glucose 
permeation rate to levels, which could only be theoretically achieved using hundreds of 
non-cross-linked bilayers. The effect of cross-linking was further probed by the 
introduction of spacer bilayers as it was expected that the nanofilm cross-linking was a 
combination of interlayer and intralayer cross-linking due to the fuzzy nature of the 
interpenetrating PEMs. Spacer bilayers lessen the degree of diffusion restriction, which 
could be useful for achieving more specific permeation rates or for the diffusion 
modulation of larger molecules. The cross-linking scheme was adapted for colloidal 
templates using glucose as a model analyte and microcapsules containing encapsulated 
glucose sensor chemistry. Cross-linked nanofilms preferentially restricted glucose 
movement over oxygen transport across the microcapsule walls, which manifested as an 
extension in the analytical range of the hydrogel based composite biosensors. 
We anticipate that similar results will be observed by cross-linking other amine 
containing components (e.g. peptides, enzymes, polysaccharides) which are commonly 
used to fabricate LbL nanofilms. This technology can be used to tailor the functionality 
of flux-based biosensors for a variety of small-molecule analytes (i.e. urea, lactate, etc.) 
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and we expect it can also play a role in controlled-release systems for applications such 
as drug delivery and self-healing coatings. Having the ability to differentially control the 
release or intake of molecules, opens the possibility to formulate multiplexed and 
multifunctional nanocomposite devices. Although, we demonstrated the use of 
composite hydrogels to sense glucose in the physiological range, additional 
modifications to the design scheme are necessary for in vivo operation. Implantable in 
vivo sensors mandate greater operational stability and reliable sensor response at 
physiologically low oxygen conditions. In the next chapter, modifications to our sensor 
design for operation under in vivo conditions will be discussed. Future work will also 
focus on the development of these unique microcapsule enabled hydrogel based devices 
for multi-analyte sensing and theranostic applications. 
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4. COMPOSITE HYDROGELS WITH ENGINEERED MICRODOMAINS FOR 
OPTICAL GLUCOSE SENSING AT LOW OXYGEN CONDITIONS * 
 
4.1. Introduction 
 Fully-implantable bioresponsive materials offer potential to overcome issues 
associated with minimally-invasive, electrochemical sensors; however, devices proposed 
for implantation carry stringent requirements. Any sensing material that is completely 
implanted should satisfy the following basic criteria: (1) soft biomaterial possessing 
small form factor and mechanical properties similar to the surrounding tissue;116 (2) 
high-fidelity response over the biologically relevant range;117 and (3) long-term 
stability.118 Insensitivity to electromagnetic interference (EMI) and low/zero-power 
operation with facile recharging are additional desirable properties.119 To meet these 
requirements in an approach that offers the additional advantage of avoiding the use of 
implanted electronics, our group has recently developed bioresponsive materials that 
respond to lactate and glucose by covalently immobilizing oxidoreductase enzymes and 
an oxygen-sensitive metalloporphyrin dye within biocompatible hydrogel matrices. 101, 
102 These unique materials transduce chemical concentration into optical information 
(phosphorescence intensity or lifetime). While these materials were found to exhibit the 
desired response characteristics in benchtop testing, it was observed that the response  
 
* Reprinted with permission from “Composite Hydrogels with Engineered Microdomains for Optical 
Glucose Sensing at Low Oxygen Conditions” by Bornhoeft. L.R., Biswas. A., McShane. M.J. MDPI 
Biosensors 2017, 7(1), 8.  Copyright 2017 by Multidisciplinary Digital Publishing Institute. 
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often saturated at relatively low analyte concentrations when used in vivo; this undesired 
outcome has been attributed primarily to low tissue oxygen levels which have been  
found to be ~ 3 times lower than air-equilibrated aqueous solutions. 120, 121 These low 
oxygen concentrations disrupt the function of the bioresponsive material because they 
were designed and lab-proven based on a diffusion-reaction equilibrium expecting 
higher oxygen concentrations. Modification of the materials to address this issue 
requires drastic reduction of analyte flux; this is essential because enzymatic 
bioresponsive materials require a delicate balance between analyte diffusion and reaction 
to produce a signal that varies sensitively over the entire analyte concentration range of 
interest.122, 123 The use of PEMs to form responsive microdomains dispersed in hydrogel 
matrices to control glucose diffusion was recently demonstrated as an effective means to 
“tune” the optical response; these responsive materials are capable of preferentially 
reducing glucose flux while not affecting oxygen diffusion kinetics.55, 124 However, the 
relatively low enzyme stability (Figure 11) in the hollow microdomains of these 
materials was insufficient to support use in long-term sensing applications as described 
in Chapter 3. In contrast, ionically-crosslinked alginate, a polysaccharide with mild 
encapsulation and gelation techniques, was chosen as an improvement in the material to 
enhance enzyme stability.125, 126 
 In this work, the same principle of transport control via nanofilm coatings on 
microdomains mentioned above was adapted for application to alginate microparticles 
that were subsequently embedded in alginate hydrogels. We hypothesized that the 
sensitivity to different oxygen concentrations could be influenced by the composition of 
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the nanofilm coating and that there would be a substantial increase in stability by 
protecting and immobilizing enzymes within alginate microparticles. This design was 
expected to leverage the advantages of different systems studied in our previous work, 
providing enzyme stability along with the capability to fine-tune the optical response of 
the material for different applications/environments; together, these properties give a 
level of engineering control over the sensing figures of merit that, to our knowledge, has 
not been demonstrated before. 
 
4.2. Experimental section 
4.2.1. Chemicals 
 All chemicals were reagent-grade and used without further purification. Alginic 
acid sodium salt (250 cP, 2% @ 25°C), buffer salts (TRIS, 2-(N-morpholino) 
ethanesulfonic acid) ), calcium carbonate (CaCO3), 2,2,4-trimethylpentane (isooctane), 
poly (allylamine hydrochloride) (PAH, average MW 15 kDa), poly (sodium-4-
styrenesulfonate) (PSS, average MW 70 kDa), dimethyl sulfoxide (DMSO), and 
glutaraldehyde (grade II, 25% in deionized water) were obtained from Sigma Aldrich.  
β-D-glucose and calcium chloride (CaCl2) were obtained from Macron Fine Chemicals.  
Surfactants sorbitan trioleate (SPAN 85) and polyoxyethylene sorbitan trioleate 
(TWEEN 85) were obtained from Tokyo Chemical Company and Sigma Aldrich, 
respectively.  Pd-meso-tetra (4-carboxyphenyl) porphyrin (PdTCPP) was obtained from 
Frontier Scientific. Glucose oxidase (284 U/mg, Aspergillus Niger) and catalase (6500 
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U/mg, bovine liver) were obtained from BBI Solutions and Calzyme Laboratories, Inc., 
respectively.  
4.2.2. Alginate microparticle synthesis 
 Alginate microparticles containing encapsulated PdTCPP, glucose oxidase 
(GOx), and catalase (Cat) were synthesized following a previously reported emulsion 
method with minor modifications 86. Briefly, 5 mL of aqueous solution containing 3 w/v 
% alginic acid, 500 μL of 1:1 molar ratio GOx (11.7 mg) and Cat (18.3 mg) in 50 mM 
TRIS buffer (pH 7.2), and 500 μL of 10 mM PdTCPP in DMSO were added drop-wise 
and emulsified in a solution containing 10.8 mL isooctane (99%) with 170 μL  SPAN 85 
(1.55 v/v %) using a homogenizer (IKA T25, S25N18G dispersing tool) operating at 
8000 rpm for 2 min. A second surfactant solution containing 1.5 mL isooctane (99%) 
with 96 μL TWEEN 85 (6 v/v %) was added and homogenized at the same speed for 1 
min. For external gelation of alginate microparticles, 4 mL of 10% w/v CaCl2 solution 
was added and the emulsion was stirred gently in a round bottom flask for 20 min. 
Alginate microparticles were washed with deionized water and collected after 
centrifugation (2000g for 2 min).  
 
4.2.3. Layer-by-Layer (LbL) deposition on alginate microparticles 
 Nanofilms were deposited on alginate microparticles by alternately adding 1 mL 
of 20 mg/mL PAH (pH 8) and 1 mL of 20 mg/mL PSS (pH 7.2) to microparticles and 
washing between each deposition with 10 mM TRIS buffer (pH 8 and pH 7.2, 
respectively) until the desired number of layers were applied. Studies of diffusion 
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inhibition by the nanofilms have been previously performed to evaluate the relationship 
between the number of layers and flux of glucose and oxygen; 124 based on those 
findings, 10 bilayers were used for this work. Covalent crosslinking of the PAH amine 
groups was performed by mixing 4.4 mg of LbL-coated alginate microparticles with 20 
mL of 3 M glutaraldehyde and gently stirring for 30 min at room temperature. Particles 
were washed with deionized water and stored at 4°C in a solution containing 10 mM 
TRIS (pH 7.2) and 10 mM CaCl2. 
 
4.2.4. AnA fabrication: alginate microparticles embedded in alginate hydrogel 
 The alginate hydrogel fabrication process was based on a previously reported 
internal gelation method with minor modifications.103 Briefly, alginate microparticles 
(75 μL, 8.8 mg) were mixed with 200 μL of 3 w/v% alginate and 25 μL of 33.3 mg/mL 
CaCO3. Dissolution of CaCO3 was initiated by addition of 100 μL of 10 mM MES buffer 
(pH 6.1). The solution was vortexed and quickly transferred to a 1.5 mm-thick Teflon 
and glass mold and allowed to gel for 15 min. AnA hydrogels were then punched into 
discs (4 mm diameter, 1.5 mm thick, Fig. 1c) using a biopsy punch. All materials were 
stored in a solution containing 10 mM TRIS (pH 7.2) and 10 mM CaCl2 and allowed to 
equilibrate overnight before use.  
  
4.2.5. Diffusion measurements 
 LbL polyelectrolyte nanofilms were deposited on 0.2 μm filters (Anapore) by 
alternately adding 1 mL of 20 mg/mL PAH (pH 8) and 1 mL of 20 mg/mL PSS (pH 7.2) 
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to the filters while washing between each deposition with 10 mM TRIS buffer (pH 8) 
until the desired number of layers were applied. Covalent crosslinking of the nanofilms 
was performed by adding 1 mL of 3 M glutaraldehyde for 30 min at room temperature 
followed by rinsing with deionized water. The nanofilm-coated Anapore filters were 
placed in a side by side permeate chamber (Permegear Inc.) with the feed chamber 
containing 7 mL of a 1 g/L glucose solution and the permeate chamber containing 7 mL 
of a 10 mM TRIS buffer (pH 7.2). Samples were taken at regular time points from both 
chambers and analyzed with an YSI Biochemistry Analyzer (Model 2700). The change 
in concentration over time (dC/dt) was calculated using linear regression. 
 
4.2.6. Oxygen and glucose challenges 
 AnA hydrogels were immobilized in a custom-built flowcell previously reported 
elsewhere.124 Oxygen challenges were performed by exposing the AnA hydrogels to 
varying dissolved oxygen concentrations (0-206.8 μM, 37 °C). The oxygen 
concentration was adjusted using mass flow controllers (1179A, MKS). Glucose 
challenges were performed by exposing the AnA hydrogels to varying physiologically 
relevant glucose concentrations (0-400 mg/dL in 10 mM TRIS with 10 mM CaCl2, 
37°C) at fixed oxygen concentrations (206.8 μM for ambient and 70 μM for interstitial 
oxygen concentration).120 The oxygen concentration was regulated by a vacuum 
degasser (9000-1118, Systec). All optical measurements were recorded using a custom-
built time domain phosphorescence lifetime measurement instrument with a 530 nm 
excitation source described elsewhere. 101, 102 The combination of the AnA hydrogel 
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(bioresponsive material) with the lifetime measurement unit (detector) will be referred to 
as the “sensing system.” The glucose challenge data of phosphorescence lifetime versus 
concentration were fit using a sigmoidal function in MATLAB (version R2015a). The 
upper and lower limits of detection (ULOD and LLOD, respectively) used to calculate 
the dynamic range (ULOD-LLOD) for each glucose challenge were calculated by using 
the 3-σ method described elsewhere.12 The sensitivity was calculated by dividing the 
difference in phosphorescence lifetime values at the ULOD and LLOD by the dynamic 
range. All statistical tests were performed using GraphPad Prism (version 7.0a). 
 
4.2.7. Scanning electron microscopy of alginate  
 Bare and nanofilm-coated alginate microparticles were imaged using a scanning 
electron microscope (SEM, JEOL 7500, 15 kV). Samples were prepared by pipetting 2 
μL of a 1:20 dilute solution of microparticles onto a silicon wafer and drying in a 
vacuum desiccator overnight. The samples were sputter coated with Pd/Pt (2.5 nm) prior 
to image acquisition. 
 
4.2.8. Darkfield and hyperspectral imaging of AnA hydrogels 
 AnA hydrogels (4 mm biopsy punch) were used for darkfield and hyperspectral 
imaging using a research grade optical microscope (BX51, Olympus, 60x oil, variable 
NA iris, aluminum quartz halogen source lamp) equipped with an enhanced darkfield 
illumination condenser system. Hyperspectral image acquisition was obtained with a 
diffraction grating hyperspectral imager, integrated CCD, and line scan or “pushbroom” 
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system. CytoViva software (customized ENVI hyperspectral image software, nanoscale 
analysis) was used for all image processing. 
 
4.3. Results and discussion 
 
 
 
Figure 12. AnA hydrogels: composition and microscopic imaging. (A) Illustration of an 
alginate microparticle containing PdTCPP, GOx, and Cat coated with 10 bilayers of PAH 
and PSS. (B) AnA hydrogel with embedded PEM-coated alginate particles. (C) 
Photograph of AnA hydrogel next to a penny. SEM micrograph of (D) uncoated and (E) 
coated alginate microparticles, respectively. Scale bars = 1 μm for both micrographs. (F) 
Darkfield optical image of the AnA hydrogel containing alginate microparticles 
distributed throughout an alginate matrix. Scale bar = 10 μm.  
 
 
4.3.1. Characterization of the AnA hydrogels  
 Fig. 1a-b illustrate an alginate microparticle, synthesized by a water-in-oil 
emulsion method, containing PdTCPP, GOx, and Cat before and after LbL nanofilm 
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deposition of 10 bilayers of PAH and PSS (denoted as [PAH/PSS]10). The bare and 
coated microparticles were imaged to reveal morphological differences using SEM, as 
shown in Figure. 12 D-E, respectively. The textured surface of the uncoated 
microparticles resulted from residual CaCl2 salt but was much smoother than the LbL-
coated spheres, which exhibit increased surface roughness. After characterization of the 
alginate microparticles, the AnA hydrogel (Figure 12C) was fabricated by the internal 
gelation method described above. Darkfield microscopy of the AnA hydrogel (Figure 
12F) shows individual alginate microparticles distributed throughout the 1.5 mm thick 
alginate hydrogel. The reflectance spectrum and hyperspectral imaging of Figure 12F 
showed an absence of signal in areas of the hydrogel where there was an absence of 
sensing microdomains indicating confinement of PdTCPP to the nanofilm bound 
microparticles. (Figure 13) 
 
 
 
Figure 13. (A) Reflectance spectrum of encapsulated PdTCPP embedded within the AnA 
hydrogel. The decrease in the reflectance value, indicated by a black line at 530 nm, 
correlates to the excitation wavelength of PdTCPP.  (B) Hyperspectral map of a section of 
the AnA hydrogel with false red color identifying encapsulated PdTCPP at multiple focal 
planes. Scale bar = 10 µm. 
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4.3.2. AnA hydrogel response 
 Following synthesis and characterization of the alginate microparticles and AnA 
hydrogels, performance of the full system was evaluated. The sensing capability of this 
system is governed by the following well-known enzymatic reaction in the presence of 
GOx: glucose + O2 + H2O → gluconic acid + H2O2. Glucose and molecular oxygen 
diffuse into the sensing material, and glucose is catalytically converted into gluconic 
acid and hydrogen peroxide by the oxidoreductase enzyme GOx. This reaction results in 
the consumption of and decrease in local glucose and oxygen concentrations. The co-
immobilized phosphorescent porphyrin dye (PdTCPP) is collisionally quenched by 
molecular oxygen, resulting in phosphorescence intensities and lifetimes that are 
inversely proportional to the local oxygen concentration.127 As oxygen decreases, 
PdTCPP is quenched less; with the co-substrate reaction scheme, this results in 
increasing phosphorescence lifetimes that are directly correlated with glucose 
concentrations within the AnA hydrogel. As a result, the systems employing enzymatic 
AnA hydrogels are flux-based, where performance relies on the ability to control relative 
diffusion of oxygen and glucose. 
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Figure 14. (A) Plot showing the difference in the rate of glucose permeation through 10 
bilayers of PAH/PSS without (blue ○) and with (green □) glutaraldehyde crosslinking. (B) 
The phosphorescence lifetimes of AnA hydrogels containing 10 bilayers of PAH/PSS 
plotted against oxygen concentrations for particles without (blue ○) and with (green □) 
glutaraldehyde crosslinking. Error bars for both plots represent 95% confidence intervals 
for three separate samples. 
 
 
 To tune the sensitivity of AnA hydrogels under different oxygen conditions, we 
aimed to control the nature of the diffusion-limiting coatings on the surface of the 
alginate microparticle. Glutaraldehyde crosslinking of the amine groups on PAH has 
been shown as an effective method to significantly reduce glucose permeation; therefore, 
AnA hydrogels containing alginate microparticles without and with crosslinking were 
synthesized.124 We quantitatively assessed the effect crosslinking has on the diffusion of 
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glucose across planar Anapore filters containing 10 bilayers of PAH/PSS and found a 
179% decrease in the glucose permeation rate when crosslinking was introduced (Figure 
14A). Next, we evaluated the optical phosphorescence lifetime response when oxygen 
concentrations were varied by using the Stern Volmer relationship: τ0/τ = 1 + KSV [O2]. 
The normalized phosphorescence lifetime (τ0/τ) was plotted against oxygen 
concentration ([O2]) in order to calculate the Stern Volmer quenching constant (KSV), 
summarized in Table 2 below. We found no statistical difference between AnA 
hydrogels without and with crosslinking at oxygen levels lower than 115 μM (p > 0.05, 
Figure 14B), which represents the expected operating conditions (<100 μM [O2]) for an 
in vivo implantable glucose bioresponsive material. With this system, we control the 
analyte flux only, while the oxygen concentration remains unperturbed; this is especially 
key for environments that are limited in oxygen supply. 
 Figure 15A is a graph of the phosphorescence lifetime response to glucose 
concentration changes, which clearly presents the biosensing capability of this system. 
The AnA hydrogels were tested at physiologically relevant glucose concentrations (0-
400 mg/dL) and at two different oxygen levels, ambient (206.8 μM) and interstitial (70 
μM). Calibration curves were generated for each response, and the ULOD and LLOD 
were calculated in order to determine the dynamic range and sensitivity for each AnA 
hydrogel. At ambient conditions, the AnA hydrogels containing non-crosslinked 
microparticles respond over a wide dynamic range of 5.7-330 mg/dL with a sensitivity 
of 0.80 ± 0.11 μs dL mg-1. In contrast, AnA hydrogels containing crosslinked LbL 
coated microparticles under ambient conditions exhibit only a slight increase in the 
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optical response with phosphorescence lifetimes of 115-150 μs correlating to a dynamic 
range of 87-350 mg/dL and low sensitivity of 0.075 ± 0.013 μs dL mg-1 when exposed 
to glucose. This difference observed at ambient conditions is due to an imbalance in the 
analyte diffusion kinetics, where the low glucose flux relative to oxygen flux results in a 
lack of sensitivity when using crosslinked LbL coated microparticles within the AnA 
hydrogels. Specifically, glucose diffusion through AnA hydrogels with crosslinked 
microparticles is so slow relative to oxygen that the reaction does not effectively deplete 
oxygen locally. At low oxygen levels, however, a decrease in glucose diffusion is 
necessary in order to prevent saturation of the signal. AnA hydrogels containing non-
crosslinked particles immediately saturated when exposed to the lowest concentration of 
glucose. Alternatively, AnA hydrogels containing crosslinked microparticles have a 
linear response at physiologically-relevant glucose and oxygen concentrations with a 
dynamic range of 2.6-350 mg/dL and sensitivity of 0.97 ± 0.054 μs dL mg-1. The 
sensing figures of merit are summarized in Table 2 for AnA hydrogels containing either 
non-crosslinked or crosslinked microparticles at ambient and low oxygen. These results 
demonstrate the ability to control the desired optical response by carefully engineering 
the diffusion-limiting coating on alginate microparticles; this is extremely important 
when translating this bioresponsive composite hydrogel design to in vivo applications. 
We note some of our parallel efforts specifically address some of the questions 
pertaining to subcutaneous deployment of such responsive materials. Specifically, we 
have performed studies with live subjects (animal and human models) to assess the 
potential for successful in vivo application of similar materials. These comparable 
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sensing systems consisting of implantable hydrogel based materials with longer-
wavelength benzoporphyrin phosphors (with red-light excitation, compared to the green-
excited phosphors used here) and along with a complementary phosphorescence 
detection instrument with red LED and filters matching the long wavelength emission. 
101, 128 These studies describe a strategy that appears effective for in vivo use and should 
be applicable to the AnA hydrogels described here, but they will similarly require a shift 
to longer-wavelength phosphors to enable the deeper tissue penetration. 
 To better understand the AnA hydrogel performance and further underscore the 
necessity to tune the sensitivity and dynamic range, we compared a numerical simulation 
of glucose finger prick measurements with predicted AnA hydrogel response values. 
Figure 15 B-C present graphs of reference glucose values overlaid on a plot of predicted 
AnA hydrogel response values that would be expected from non-crosslinked or 
crosslinked microparticles calibrated and operated at ambient and low oxygen. The 
glucose values represent measurements from finger prick blood glucose measurements. 
The predicted optical response values were extrapolated from the calibration curves 
generated from Figure 15A and are associated with each individual glucose 
measurement. Figure 15B shows that incorporation of non-crosslinked microparticles at 
ambient oxygen concentrations correlate relatively strongly with simulated glucose 
values (r = 0.810), indicating that the oxygen concentrations at ambient conditions are 
high enough that they do not necessitate an increased diffusion barrier and decrease in 
analyte flux. Although AnA hydrogels containing crosslinked microparticles also 
correlate remarkably well with glucose when tested at ambient oxygen (r = 0.998, Figure  
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Figure 15. Calibration and performance stability of AnA hydrogels.  (A) AnA hydrogel 
response to varying glucose concentration (0-400 mg/dL) for non-crosslinked (blue ○ or 
red ○, ambient and low oxygen, respectively) and crosslinked (blue □ or red □, ambient 
and low oxygen, respectively) microparticles. Error bars represent 95% confidence 
intervals for three separate samples of the same formulation. (B,C) Simulated blood 
glucose levels (green, left axis) collected over time and predicted response of each AnA 
hydrogel (blue and red, right axis). The predicted values indicate estimated responses from 
calibration of materials containing either non-crosslinked (blue ○ or red ○, ambient and 
low oxygen, respectively) or crosslinked (blue □ or red □, ambient and low oxygen, 
respectively) microparticles.  
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15B), the sensitivity is too low to distinguish between the phosphorescence lifetime 
values for most practical applications. Alternatively, the AnA hydrogels with non-
crosslinked microparticles tested at low oxygen generate a constant, saturated response; 
here, no correlation between predicted phosphorescence lifetime values and input 
glucose values is expected. Crosslinked microparticles are essential for a robust response 
at low oxygen levels; these predictions show dramatically improved correlation with 
reference glucose values (r = 0.904, Figure 15C). 
 
 
 
Figure 16. Stability of the AnA hydrogel. Cyclic testing of AnA hydrogel consisting of 
crosslinked microparticles tested at interstitial oxygen levels over 2 days. Glucose was 
varied between 0 mg/dL (orange X) and 400 mg/dL (purple ∆). Error bars represent 95% 
confidence intervals for three separate samples.   
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Table 2. Figures of merit calculated for AnA hydrogels with and without crosslinked 
microparticles at ambient and low oxygen.a 
 
 Non-crosslinked Crosslinked 
τ0 (μs) 603 ± 16.3 588 ± 22.3 
Ksv (O2 %)  1.9 ± 0.072 2.3 ± 0.017 
Ambient O2    
Dynamic Range (mg/dL) 5.7-330 87-350 
Sensitivity (μs × dL/mg) 0.80 ± 0.11 0.075 ± 0.013 
     
Low O2    
Dynamic Range (mg/dL) b--- 2.6-350 
Sensitivity (μs × dL/mg) b--- 0.97 ± 0.054 
 
a Data is calculated based off of three separate AnA hydrogels from the same 
formulation with 95% confidence intervals. b AnA hydrogel saturated immediately after 
first glucose concentration; Metrics not determined. 
 
 
4.3.3. AnA hydrogel stability 
  Biosensing materials containing a bioactive enzyme often loose function over 
time due to enzyme degradation by various mechanisms, including spontaneous enzyme 
denaturation and peroxide poisoning 129, 130. Catalase is an enzyme found in many 
organisms utilized for the catalysis of hydrogen peroxide into water and oxygen and has 
been incorporated into enzymatic glucose responsive hydrogels to mitigate peroxide 
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poisoning 110, 131. By co-immobilizing catalase with glucose oxidase in our 
microparticles, the stability was expected to increase with respect to sensors not having 
catalase; this has been extensively demonstrated by multiple research groups over the 
last couple of decades.105, 132-134 Indeed, Figure 16 shows the remarkable stability of the 
AnA hydrogel containing crosslinked alginate microparticles tested at an interstitial 
oxygen concentration (70 μM [O2]). The hydrogels were tested repeatedly over the 
course of two days at the extreme physiological values of 0 and 400 mg/dL. The 
phosphorescence lifetime data points for each glucose concentration (0 and then 400 
mg/dL) were fit with a linear regression line. Although there appears to be a slight 
increase and decrease in the phosphorescence lifetime values at 0 and 400 mg/dL, 
respectively, there was no statistically significant difference in optical response from 
start to end at either of the two concentrations studied (p > 0.05). Using linear regression 
to predict the rate of degradation, it was estimated that the AnA hydrogel when exposed 
to these extreme, cyclic glucose concentrations would lose 50% of optical signal 
(phosphorescence lifetime, ~315 µs) at cycle 173; this translates to a functional working 
lifespan of ~ 2 weeks.  
 
4.4. Conclusion 
 Alginate hydrogels embedded with alginate microparticles containing oxygen-
sensitive phosphors and oxidoreductase enzymes were demonstrated as stable optical 
bioresponsive materials. This combination offers a number of attractive features. In 
terms of performance, these materials exhibit precisely-controlled diffusion of glucose 
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and oxygen into the discrete biosensing domains, which is necessary for accurate sensing 
at low, physiologically relevant oxygen concentrations. The AnA hydrogels were 
designed for in vivo sensing applications where long-term stability is necessary; here, we 
showed remarkable stability even after two days of cyclic exposure to extreme glucose 
concentrations. The sensors lose 50% of its optical signal in two weeks, supporting the 
possibility for use as an implantable sensing material. The stability is attributed to the 
supportive environment of the alginate microparticles wherein the enzyme is physically 
trapped. This demonstration of effective control of sensitivity and dynamic range by 
adjusting the properties of nanofilm coatings on microscale inclusions opens the door for 
application of a new class of engineered materials for sensing.  The same approach will 
be applicable when adapting these materials for sensing with other oxidoreductase 
enzymes for the monitoring of different chronic conditions; the next chapter 
demonstrates the use of this modular design to develop lactate sensors.    
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5. NANOCOMPOSITE HYDROGELS CONTAINING BIOACTIVE 
MICROREACTORS FOR OPTICAL ENZYMATIC LACTATE SENSING 
 
5.1. Introduction 
 As discussed in earlier sections enzymatic biosensors commonly contain an 
oxidoreductase enzyme (oxidase or dehydrogenase) that catalyzes the enzymatic 
utilization of the substrate accompanied by a specific product formation; substrate 
depletion and/or byproduct formation is then monitored optically or 
electrochemically.135 In Section 4 the use of nanofilm coated alginate microparticles 
(AlgMPs) containing specific sensing chemistry was demonstrated for use as glucose 
sensors that operate at physiologically low oxygen. It was hypothesized that the 
microparticle sensors are modular in nature and that by replacing the glucose oxidase 
with other oxidoreductase enzymes the functionality of the sensors could be easily 
altered; in this section we demonstrate the application of AlgMPs for use as lactate 
sensors. Lactate, a primary byproduct of anaerobic metabolism has been an analyte of 
interest among researchers due to its relevance in the food industry, sports medicine, and 
critical care.136-138 Monitoring blood lactate concentrations in patients with severe 
ketoacidosis is essential, to prevent muscle damage and potential heart attack. 139 
Additionally, lactate tracking can be used to identify patients requiring resuscitative care 
in the event of significant blood loss.140 
 Nearly all enzymatic lactate sensors described to date have been based on planar 
or cylindrical transducers (e.g. wires, optical fibers, patterned electrodes, or waveguides) 
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with a coating applied to the outer surface to control analyte transport.141-144 These 
devices require physical connections for measurements and have a narrow range of 
possible mechanical properties, limiting their potential use in many applications 
especially in the biomedical space. Here, we describe a unique lactate sensing platform 
relying on the combined effect of a population of microdomains dispersed within a 
hydrogel matrix to generate a measurable change in an optical property 
(phosphorescence). In this format the microdomains (Figure 17A) contain bioactive 
lactate oxidase and a reporter dye, and are lined by polyelectrolyte multilayers (PEMs); 
the PEM coating provide a means to control local diffusion properties and to alter sensor 
response. Optical sensors based on these active domains embedded within a soft 
hydrogel are suitable for aqueous analysis, including potential use as implantable 
devices if an appropriately biocompatible matrix is employed.  
 In enzymatic lactate sensors, LOx (lactate oxidase) catalyzes the oxidation of 
lactate in the presence of molecular oxygen, ultimately producing pyruvate (lactate + O2 
+ lactate oxidase + H2O  →  pyruvate + H2O2); just like the glucose sensors described, 
these lactate sensors should be substrate-transport limited rather than reaction-kinetics 
limited. 83 In this work we hypothesized that PEM lined microreactors entrapped in an 
outer hydrogel matrix can be used as optical lactate biosensors that work reversibly at 
physiologically relevant oxygen conditions. For the first time, we fabricated nanofilm-
bounded LOx and phosphor-containing microreactors using alginate microparticle 
templates, which were ultimately dispersed in an alginate matrix to be used as 
nanocomposite hydrogel based lactate sensors. We evaluated the response of these 
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sensors to lactate at ambient and low oxygen concentrations and furthermore, we 
examined the stability of these sensors to repeated cyclic lactate exposure. 
 
 
 
Figure 17. (A) Representation of lactate sensing AlgMPs coated by LbL nanofilm coating 
(B) flow through system and reader head used to test the hydrogel based lactate sensors.  
 
 
5.2. Experimental section 
5.2.1. Chemicals 
 Sodium L-lactate, calcium carbonate (CaCO3), poly (sodium-4-styrenesulfonate) 
(PSS, average MW 70 kDa), poly (allylamine hydrochloride) (PAH, average MW 15 
kDa), alginic acid sodium salt (250 cP, 2% @ 25°C), buffer salts (TRIS, MES), 
polyoxyethylene sorbitan trioleate (TWEEN 85), 2,2,4-trimethylpentane (isooctane), 
dimethyl sulfoxide (DMSO), and calcium chloride (CaCl2) were obtained from Sigma 
Aldrich. Pd-meso-tetra(4-carboxyphenyl) porphyrin (PdTCPP), lactate oxidase 
(Aerococcus viridians), and catalase (Bovine Liver) were obtained from Frontier 
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Scientific , AG Scientific and Calzyme Laboratories respectively. All chemicals were 
used as received. 
 
5.2.2. Alginate microparticle (AlgMP) and hydrogel sensor fabrication 
 Lactate oxidase (LOx), catalase (Cat), and PdTCPP containing alginate 
microparticles (AlgMPs) were fabricated using a slightly modified emulsification 
method. 86 Alginic acid (5 mL, 3% wt), enzyme solution (14 mg LOx and 21.9 mg Cat 
suspended in 500 µL, 50 mM TRIS buffer (pH 7.2)), and PdTCPP solution (10 mM in 
DMSO) were added dropwise to a round bottomed flask containing a mixture of 10.8 
mL iso-octane (75 g) and 170 µL of SPAN 85 (1.7 g), and emulsified at 8000 rpm for 2 
min using a homogenizer (IKA T25, S25N18G). After 2 min 96 μL of another surfactant 
TWEEN 85 (0.904 g) dissolved in 1.5 mL isooctane (5 g) was added and further 
homogenized for an additional minute. To the resulting mixture 4 mL of CaCl2 (10% 
w/v) solution was added and gently stirred for 20 min to allow ionotropic gelation of the 
AlgMP sensors. The AlgMPs were washed thoroughly (3 times) with DI water before 
further use. 
 To deposit PEM nanofilms the AlgMPs were alternately exposed to 1 mL PAH 
(20 mg/mL, pH 8) and 1 mL PSS (20 mg/mL, pH 7.2) and washed with 10 mM TRIS 
buffer (pH 8) between each PEM deposition step, until the desired number of bilayers 
are achieved. Nanocomposite hydrogel sensors containing nanofilm coated AlgMPs 
were fabricated using a previously reported protocol.115, 124 Briefly, 8.8 mg of nanofilm 
coated AlgMPs, 0.8 mg of CaCO3 particles, 200 μL of alginate (3 w/v %), and 100 μL of 
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10 mM MES buffer (pH 6.1) were mixed to make a slow gelling mixture. The gelling 
mixture was then poured between two glass slides separated by a 0.06’ Teflon spacer 
and allowed to gel for 30 min to make the hydrogel sensor slabs. The hydrogel slabs 
were stored in 10 mM TRIS (pH 7.2) containing 10 mM CaCl2 and allowed to 
equilibrate overnight before use. 
 
5.2.3. Characterization  
 Zeta potential data was collected using a Zeta Sizer Nano Series ZEN 3600 
Spectrometer (Malvern Instruments Ltd.). For all zeta potential measurements, 1/1000 
diluted stock in 5 mM TRIS pH 9 buffer containing 1 mM CaCl2 was used.  
 Scanning electron microscopy (SEM) images of nanofilm lined AlgMPs and 
nanocomposite hydrogels were obtaining using a JEOL 7500 SEM. The AlgMP stock 
was diluted to 1/1000, and 2 µL of the diluted solution was placed on a silica wafer and 
dried overnight before imaging. 
 Fluorescent micrographs of hydrogels containing AlgMPs were obtained using 
an Olympus IX81 inverted laser spinning-disk confocal microscope. Samples were 
excited at 488 nm and viewed using a 40X oil immersion objective. Pseudo colored 
ratiometric image was obtained by dividing the AlgMP pixel intensities at reduced 
oxygen and AlgMP pixel intensities at ambient oxygen. All images were analyzed using 
ImageJ 1.48v software. 
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5.2.4. Sensor testing 
 Lactate sensor discs (4 mm) excised from the hydrogel sensor slabs, were affixed 
in a custom made flow cell (Figure 17B)and exposed to varying concentrations of 
dissolved oxygen (0 – 103.4 µM) and lactate (0-40 mg/mL). Dissolved oxygen 
concentration of buffer was controlled using mass flow controllers (1179A, MKS). 
Lactate challenges at physiologically low oxygen concentrations were performed by 
using a vacuum degasser (9000-1118, Systec). Lifetime response of the sensors were 
collected using a custom made time domain system with a 530 nm LED excitation 
source that has been described previously.102 Lower limit of detection (LOD) and 
maximum differentiable lactate concentration (MDLC) were determined using the 3-σ 
method. 115 The analytical range was defined as R = MDLC-LOD and sensitivity was 
calculated using the percentage change of maximum and minimum response of the 
sensor per unit analytical range. 
 
5.3. Results and discussion 
5.3.1. Characterization 
 PEMs were deposited on LOx/CAT/PdTCPP containing AlgMPs using the LbL 
approach that involves coating the AlgMPs with oppositely charged polyelectrolyte 
layers. The zeta potential (Figure 18A) of the AlgMPs was measured to confirm 
successful surface charge reversal after deposition of each PEM. The polyelectrolyte 
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lined AlgMPs exhibited a high degree of colloidal stability owing to its high surface 
charge; -20.6±2.4 for PSS coated AlgMPs and 49.7±5.2 for PAH coated AlgMPs. After 
deposition of 10 bilayers, the nanofilm coated AlgMPs were used to fabricate lactate 
sensing nanocomposite hydrogels. SEM images revealed the morphology of both the 
nanofilm coated AlgMPs (Figure 18B) and the nanocomposite lactate sensing hydrogels 
(Figure 18C). The [PSS/PAH]10 coated AlgMPs were spherical and covered by a fuzzy 
outer layer, characteristic to PEM coated colloidal particles. 145, 146 SEM images of the 
hydrogel depicts multiple AlgMPs with a wrinkled architecture entrapped within an 
outer hydrogel matrix. DIC images were used to determine the mean diameter of the 
[PSS/PAH]10 coated AlgMPs as ~8 µm. From the confocal image (Figure 18D) it can be 
clearly seen that the phosphorescent PdTCPP dye is restricted within the PEM lined 
alginate microreactors which is expected as the nanofilm coating localizes the 
macromolecules (LOx, Cat, and PdTCPP) within the spherical microdomains. 
Furthermore, fluorescence intensity based ratiometric imaging (Figure 18E) was used to 
confirm that the lactate sensing bioreactors were sensitive to changes in oxygen; an 
intensity ratio >1 ratifies that the phosphorescence of PdTCPP in the microreactors 
increases with a decrease in oxygen level. 
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Figure 18. (A) Change in zeta potential change with increase in the number of 
polyelectrolyte layers coated on alginate microparticles. Δ = bare alginate microparticles, 
○ = PAH and □ = PSS. Error bars represent 95% confidence intervals for three separate 
batches. Scanning electron micrographs of (B) nanofilm coated alginate microparticle, (C) 
alginate hydrogel containing dispersed bioactive PEM lined alginate microparticles. 
Fluorescence microscopy images of alginate hydrogel containing dispersed bioactive 
PEM lined alginate microparticles at ambient oxygen (D) and ratiometric intensity image 
(E) under reduced oxygen to ambient oxygen. 
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5.3.2. Response to oxygen and lactate 
 To quantitatively evaluate the oxygen response, the nanocomposite hydrogels 
were exposed to varying concentrations of oxygen. The lifetime response of the 
hydrogels (Figure 19A) increases with a decrease in oxygen; plotting the normalized 
lifetime against oxygen (Figure 19A inset) and using the Stern Volmer equation τ0/τ = 
1+KSV [O2] the mean KSV was calculated to be 0.04 ± 0.001 µM-1 that is not statistically 
different (p >0.01) from previously reported values.147 It should be noted that at higher 
oxygen concentrations there is a decrease in linearity attributed to oxygen’s unequal 
accessibility to the dye molecules.148  
 Having established that the LOx/Cat/PdTCPP loaded microreactors are sensitive 
to oxygen, the response of the hydrogels to lactate was examined. We hypothesized that 
composite hydrogels containing embedded LOx/Cat/PdTCPP microdomains can 
function as enzymatic lactate biosensors; as lactate enters the bioactive reactors it is 
oxidized accompanied with a reduction in local oxygen that can then be optically 
monitored. However, the hydrogel based sensors registered no significant change 
(p>0.01) in lifetime response (Figure 19B) with increasing lactate concentrations at 
ambient oxygen (~ 21%). Investigating the permeation of lactate (Figure 20A) across 
planar [PSS/PAH]10 nanofilms deposited on porous Anopore substrates revealed that 10 
bilayers of PSS/PAH were readily permeable to lactate. Thus, there is no significant 
changes in lifetime response even though lactate is readily available to LOx contained in 
the microreactors. Additionally, when lactate was added to a highly concentrated 
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suspension (32 mg/mL) of LOx/Cat/PdTCPP containing microparticles a ~1.8 X 
increase in phosphorescence  
 
Figure 19. (A) Plot of lifetime against increasing dissolved oxygen concentration. Inset: 
Data representing change in normalized lifetime (lifetime/lifetime at zero oxygen) with 
increasing dissolved oxygen concentration. (B) Response of bioactive AlgMP containing 
hydrogels to increasing concentrations of lactate at ambient (red ◊) and low oxygen (blue 
○) condition. Error bars represent 95% confidence intervals for three separate batches of 
bioactive AlgMP containing hydrogels. 
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Figure 20. (A) Plot depicting the rate of lactate permeation across 10 bilayers of non-
cross-linked (red circle) and cross-linked (blue diamond) PAH/PSS layers deposited on 
Anopore membrane, (B) increase in phosphorescence intensity of LOx/CAT/PdTCPP 
AlgMPs suspended in a cuvette, when exposed to lactate. 
 
 
intensity at 700 nm (Figure 20B) was observed; indicating that active LOx was present 
in the AlgMPs catalyzing lactate oxidation; thus, increasing the number of particles 
within the hydrogel would engender a response at ambient oxygen but we found that 
increasing the particle concentration above what has been used for the hydrogels is not a 
practical option. We speculate that the non-responsive behavior of the AlgMPs 
containing nanocomposite hydrogel is due to PdTCPP’s low sensitivity at higher 
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ambient oxygen concentrations; PdTCPP is unable to respond considerably to minute 
fluctuations in local oxygen with changing lactate concentrations at ambient oxygen. 
 
5.3.3. Sensor stability 
 Next, we lowered the oxygen concentration to physiologically relevant ~ 5.5% 
and evaluated the response of the hydrogels to lactate. From the results reported in 
Figure 19B it can be seen that the hydrogel sensors are highly sensitive when exposed to 
lactate at low dissolved oxygen condition. The response profile of the sensor fits well to 
a sigmoidal function (R2=0.99) that was used to calculate the sensor parameters. Using 
the 3-σ method, the LOD, MOLC, and analytical range (R) were calculated as 0.053 ± 
0.043 mg/dL, 9.3 ± 0.81 mg/dL, and 9.2 ± 0.83 mg/dL respectively. Additionally, the 
mean sensor sensitivity was estimated to be 11 ± 0.90 % change per unit range. It is 
important to recognize that this highly sensitive response is desirable for detection of 
low physiological levels (4.50-13.5 mg/dL) of lactate149; these findings demonstrate the 
principle of using lactate sensing AlgMPs immobilized in an alginate matrix for 
potential application as implantable hydrogel based lactate biosensors. Finally, 
reversibility and stability of the sensors were evaluated by alternately exposing the 
sensors to high (40 mg/dL) and low (0 mg/dL) levels of lactate; the concentrations of 
lactate were chosen to simulate extreme conditions. Enzymatic sensors that produce 
hydrogen peroxide as a by-product are prone to peroxide mediated enzyme denaturation, 
that ultimately leads to sensor failure over time.105 This is a well-established occurrence 
that has been extensively studied in the context of enzymatic sensors; these studies have 
also shown that the effect of H2O2 can be easily mitigated by the incorporation of Cat. 
 87 
 
105, 132-134, 141 Presence of co-immobilized Cat in the AlgMPs engenders the catalytic 
degradation of by-product peroxide and enhances the stability of the lactate sensors. The 
baseline lifetime response at 0 mg/dL lactate and the sensor response at 40 mg/dL 
showed no significant difference (p > 0.01) even after 20 cycles of repeated lactate 
exposure (Figure 21) corroborating the highly stable and reversible nature of the 
biosensors. 
 
5.3.4. Effect of crosslinking PAH/PSS coated AlgMPs 
 Finally, in an attempt to increase the analytical range of the hydrogel sensors we 
crosslinked the PAH/PSS coating on the AlgMPs. In case of the glucose sensing 
AlgMPs, crosslinking PAH/PSS layers decrease analyte diffusion and alter the sensor 
range and sensitivity; thus, we speculated that we would observe similar effects in case 
of lactate sensing AlgMPs. We observed (Figure 22) that crosslinking the nanofilm 
coated AlgMPs with different concentrations (0.375 – 3 M) of glutaraldehyde decreased 
(4X) lactate permeation drastically (Figure 20 A) reducing sensitivity to the extent that 
the sensors were unusable. The hydrogels containing non-coated AlgMPs showed a 
sensitivity of ~110.4% whereas the hydrogels containing AlgMPs exhibited an average 
sensitivity of ~8% (FEAS 24) and ~2.3% (GRN 1) when tested using two different 
reader heads that house the excitation source and the detector, FEAS24 and GRN1 
respectively. 
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Figure 21. Cyclic testing of lactate sensors when alternately exposed to 0 mg/dL and 40 
mg/dL lactate at low oxygen. Error bars represent 95% confidence intervals for three 
separate batches of bioactive AlgMP containing hydrogels. 
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Figure 22. Response of cross-linked PAH/PSS coated AlgMP containing nanocomposite 
hydrogels to lactate (0 mg/dL - 40 mg/dL) at low oxygen. 
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5.4. Conclusion 
 This work has shown the ability to use nanocomposite hydrogels as reversible 
and stable optical lactate sensors; these hydrogels are embedded with PEM lined 
bioactive AlgMPs that contain encapsulated enzyme and oxygen sensitive porphyrin 
dye. The LbL nanofilms were able to fine-tune the transport of oxygen and lactate into 
the bioactive microreactors for successful lactate sensing. We demonstrated that these 
sensors were highly sensitive (~ 101.2%) in the range 0.05 – 9.3 mg/dL when operated at 
physiologically low oxygen levels, which is necessary for in vivo sensing. Additionally, 
these sensors exhibited extraordinary stability when repeatedly exposed to high lactate 
levels further supporting possible long term in vivo use. The high degree of stability is 
ascribed to enhanced GOx stability due to: (1) the presence of co-immobilized Cat that 
removes detrimental H2O2 and (2) stabilization of GOx’s tertiary structure due to 
interaction with the surrounding polymer matrix.150 This nanocomposite hydrogel based 
sensor design can be easily modified to sense other chronic disease biomarkers (e.g. 
cholesterol, urea) by switching the oxidoreductase enzyme. In future, we will be using 
our sensors for implantation in animal models to evaluate in vivo sensor response. The 
next chapter focusses on how microdomains embedded in hydrogels behave in a 
cooperative manner to produce a changes in sensor response. Additionally, the limits of 
hydrogel based sensors for use as multianalyte and multiplexed sensors are also 
discussed. 
 91 
 
6. INVESTIGATING COOPERATIVE EFFECT IN COMPOSITE HYDROGEL 
BASED ENZYMATIC SENSORS 
 
6.1. Introduction 
 As explained in the preceding chapters chronic diseases have emerged as the 
leading cause of mortality worldwide; as many chronic diseases are characterized by 
multi-metabolite concentration fluctuations, research focused on multiplexed 
(multianalyte and multimodal) analysis has been steadily gaining momentum.39 151-153 
The majority of prior developments toward sensor multiplexing has been in the field of 
amperometric sensors, which is particularly challenging; requiring complex and tedious 
techniques (electrodeposition, photolithographic patterning, and electro-polymerization) 
for spatially separated immobilization of multiple biorecognition elements (enzyme) 
onto individual electrodes. 154, 155 These limitations have driven interest into alternative 
sensor platforms, including optical systems, with flexible opportunities for optical 
multiplexing, facile fabrication options and no requirement for physical electrical 
connections. 
 Recently, hydrogel based implantable oxygen biosensors have been demonstrated 
for long term monitoring of subcutaneous tissue oxygen levels. 156, 157 These oxygen-
sensing hydrogels contain covalently crosslinked metallo-porphyrins that have been 
already extensively studied and proven quite reliable for sensing and diagnostic 
applications due to their moderately high quantum yield (~ 10-20%), highly stable 
phosphorescence, and their inherent dynamic quenching property in the presence of 
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molecular oxygen. 158, 159 Their innate long lifetime phosphorescence in the red to near-
infrared region make them ideal for in vivo applications, as there is negligible long-
lifetime auto-fluorescence from the surrounding environment and greater optical 
penetrability engendered by their long wavelength excitation and emission. 160 Such 
hydrogel based systems have been further modified and used as enzymatic sensors. 
Along these lines, we have developed and reported two effective designs for these 
hydrogel based biosensors; the use of microdomains to fabricate nanocomposite sensors 
or hydrogel based sensors with the sensing chemistry covalently attached to the matrix. 
101, 102, 55, 124  
 Optical sensors can be multiplexed (multifunctional or multianalyte) either by 
dispersing micro-sized sensing units, capable of detecting multiple analytes in a binder 
matrix or by segregating macro-sized multiple analyte sensing regions within an outer 
matrix. 161 Exploiting these strategies, there have been a few examples of optical fiber 
based multiplexed phosphorescence sensors. 162-165 However, multiplexed hydrogel 
based optical enzymatic sensors have not been reported or examined. The target analyte 
of enzymatic hydrogel based biosensors can be easily altered by substituting the oxidase 
enzyme; hypothetically, a single hydrogel system containing discrete sensing units opens 
up the possibility for multiplexing. The key aspects to consider when developing such a 
multiplexed sensor are analyte specificity and spectral cross-talk of the reporter dye. The 
spectral cross-talk conundrum can be circumvented by selecting appropriate reporter 
dyes with non-overlapping excitation and emission spectra, coupled with suitable 
instrumentation. Spectral cross-talk can also be eliminated by temporal separation 
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techniques using frequency-domain or time-domain dual lifetime acquisition. 166 The use 
of enzymes make enzymatic-biosensors highly specific to the biomolecule of interest. 
However, since most enzymatic sensors operate via transduction of a product formed or 
a co-substrate consumed, a cooperative product formation or cooperative co-substrate 
consumption interferes with potential multiplexing. 
 
 
 
Figure 23. An illustration showing a section of a hydrogel containing a mixed population 
of microdomains. 
 
 
 In this work, we examined the cooperative depletion of co-substrate oxygen in 
the vicinity of different formats of micro- and macro-sized sensors to develop and 
understand the bounds of hydrogel based multiplexed enzymatic optical sensors. Using 
cross-linked and non-crosslinked nanofilm-lined oxygen-sensing and glucose-sensing 
microdomains entrapped in the same hydrogels (Figure 23) we measured the changes in 
phosphorescence lifetime from the different microdomains with increase on glucose 
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levels to assess the extent to which micro- sensors behave cooperatively; i.e. where 
enzymatic reaction in one microdomain affects the oxygen concentrations of adjacent 
non-reactive microdomains. We further examined cooperative oxygen depletion between 
two separate, adjacent macro-sized oxygen/glucose sensing regions (Figure 24B) 
entrapped within a single encompassing hydrogel matrix (“gel-in-gel” format), as the 
size of the enzyme containing glucose macro- sensor was varied. Finally, using this gel-
in-gel (GIG) design, we fabricated and tested multiplexed glucose sensors and multi-
analyte glucose/lactate sensors for their sensitivity compared to independent sensors as a 
proof of concept to evaluate their potential as multianalyte sensing implants. 
 Nanocomposite hydrogel based glucose sensors fabricated from vaterite calcium 
carbonate particles 124 and lactate sensors made by covalently attaching sensing 
chemistry to hydrogel matrices 102 were used in this study. 
 
 
 
Figure 24. Schematic diagram of (A) sensor testing set-up: time-domain lifetime 
acquisition system and the flow cell, (B) representative glucose oxygen GIG’em sensor, 
(C) section of the glucose sensing macrodomain containing PEM lined glucose sensing 
microdomains, (D) section of the oxygen sensing macrodomain containing PEM lined 
oxygen sensing microdomains. 
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6.2. Experimental section 
6.2.1. Chemicals 
 Calcium chloride (CaCl2), sodium carbonate (Na2CO3), poly (allylamine 
hydrochloride) (PAH, average Mw 15000 Da), poly (diallyldimethylammonium 
chloride) (PDADMAC, average Mw 100000-200000 Da), poly (sodium 4-
styrenesulfonate) (PSS, average Mw 70000 Da), glutaraldehyde solution (grade II, 25% 
in H2O), alginic acid sodium salt from brown algae (100-300 cP, 2% at 25 °C), 1-ethyl-
3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC), N-hydroxy 
sulfosuccinimide sodium salt (NHS), 2,2-dimethoxy-2-phenyl-acetophenone (DMAP), 
ethylene glycol, buffer salts (TRIS, MES and NaHCO3) and sodium lactate were 
obtained from Sigma Aldrich. Tetra (ethylene glycol) methacrylate (TEGDMA) and 2-
hydroxyethyl methacrylate (HEMA) were purchased from Polysciences Inc. Pd-meso-
tetra (4-carboxyphenyl) porphyrin (PdTCPP, Frontier Scientific), Pd-meso-tetra 
(sulfophenyl) tetrabenzoporphyrin (HULK, Frontier Scientific) and methacrylated 
palladium  benzoporphyrin (PdBP, donated by Profusa, Inc.) suspended in DMSO (10 
mM) were used for all experiments. Lactate oxidase from Aerococcus viridians (LOx), 
and acrylamide (Aam) were obtained from A.G. Scientific. Glucose oxidase (GOx) from 
Aspergillus niger and glucose were purchased from BBI solutions and Macron fine 
Chemicals respectively. All chemicals were used as received without further purification. 
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6.2.2. Encapsulation of sensing elements in microparticles and synthesis of 
microcapsules 
 Calcium carbonate (CaCO3) microparticles containing sensing chemistry were 
synthesized using the co-precipitation method. 167 200 µl of 10 mM PdTCPP was added 
to 8 ml solution of Na2CO3 (0.2 M) containing 64 mg of GOx and stirred (700 rpm) for 5 
min using a wedge edged stir bar. 8 ml of CaCl2 (0.2 M) was rapidly added to the 
solution of Na2CO3 containing GOx and PdTCPP and allowed to react for 10 min to 
fabricate GOx/PdTCPP loaded CaCO3 microparticles. The GOx/PdTCPP microparticles 
serve as templates to synthesize glucose sensing microcapsules. Microparticle templates 
for HULK containing glucose sensing microcapsules were made in a similar fashion 
with the only exception that 200 µl of 10 mM HULK was added to 8 ml Na2CO3 (0.2 M) 
containing 64 mg of GOx.  Microparticle templates for oxygen sensing capsules were 
also made using the same principle with minor modifications; 200 µl of 10 mM HULK 
was added to 8 ml solution of Na2CO3 (0.2 M) and stirred (700 rpm) for 5 min followed 
by the rapid addition of 8 ml of CaCl2 (0.2 M), and the reaction was allowed to continue 
for 10 min. 
 Microparticle templates were alternately exposed to oppositely charged 
polyelectrolyte solutions PDADMAC (20 mg/ml, pH 8, containing 5 mM NaHCO3) / 
PSS (20 mg/ml, pH 7.2, containing 5 mM NaHCO3) or PAH (20 mg/ml, pH 8, 
containing 5 mM NaHCO3) / PSS (20 mg/ml, pH 7.2, containing 5 mM NaHCO3) with 
wash steps in between to coat the microparticles with polyelectrolyte multilayer (PEM) 
nanofilms. Irrespective of the encapsulated cargo content, all microparticles were first 
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coated with [PDADMAC/PSS]5 to ensure a contiguous nanofilm primer coating. 168  
Following the deposition of the primer coating, GOx/PdTCPP microparticle templates 
and GOx/HULK microparticle templates were coated with [PAH/PSS]9 bilayers whereas 
HULK microparticle templates were coated with [PAH/PSS]5. To fabricate cross-linked 
nanofilm coated GOx/PdTCPP microparticles, ([PDADMAC/PSS]5-[PAH/PSS]9) coated 
microparticles containing GOx/PdTCPP (3.3 mg) was added dropwise to 3 M 
glutaraldehyde solution and allowed to react for 30 min, to cross-link the amine groups 
contained in PAH ensuring that the nanofilm coating restricts the free diffusion of 
glucose. To fabricate macromolecule-containing microcapsules, the CaCO3 
microparticle cores were dissolved by exposing the microparticle templates to a low pH 
buffer solution. Specifically 3.3 mg of nanofilm coated CaCO3 templates were 
suspended in 0.2 M MES buffer at pH 5.8 for 60 min. 
 
6.2.3. Fabrication of glucose / oxygen sensing microporous alginate composite 
(MPAC) hydrogels 
 Microporous alginate composite (MPAC) hydrogels were fabricated according to 
the principle described by Roberts et al.103 Nanofilm coated CaCO3 microparticles 
containing co-precipitated cargo (3.3 mg suspended in 75 µl of deionized water), 3% 
alginate solution (200 µl),  non-coated CaCO3 microparticles (25 µl of 33.3 mg/ml) and 
100 µl of MES (0.5 M, pH 6.1) were mixed to make a slow-gelling hydrogel precursor. 
The precursor was then poured between two glass slides separated by a 0.06” Teflon 
spacer, and allowed to gel for 30 min.  
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6.2.4. Fabrication of lactate sensing hydrogels 
 Lactate sensors were made according to the protocol described by Andrus et al. 
102 Briefly, 125 µl of enzyme solution (molar ratio LOx : Catalase :: 10:1, dissolved in 
PBS, pH 7.4), 5 µl TEGDMA, 50 µl PdBP (10 mM dissolved in DMSO), 187.5 µl 
HEMA, 62.50 µl Aam (dissolved in DMSO 67.2 v/v %), 90 µl ethylene glycol and 2.5 
mg DMAP were mixed to make a hydrogel precursor that was then poured between two 
glass slides separated by a 0.03” Teflon spacer, and allowed to gel by exposing the glass 
slides to UV light for 3 min on either side. After UV curing the gel was taken out of the 
mold and exposed to PBS buffer containing a mixture of EDC and sulfo-NHS (40 ml 
PBS containing 15 mg sulfo-NHS and 6.6 mg EDC) to cross-link the enzyme mixture to 
the hydrogel matrix.  
 
6.2.5. Fabrication of gel in gel enzymatic multiplexed (GIG’em) sensors 
 Circular hydrogel disks excised from glucose/oxygen sensing MPACs or lactate 
sensing hydrogels, were placed in a circular mold (radius = 1 cm, thickness = 1.5 mm). 
A slow gelling alginate precursor was made by mixing 250 µl of a 3% alginate solution, 
62.5 µl of non-coated CaCO3 microparticles (33.3 mg/ml), 437.5 µl deionized water and 
250 µl of MES buffer (0.5 M, pH 6.1). The slow gelling alginate precursor was then 
gently poured into the mold containing two circular hydrogel punches capable of sensing 
either glucose, lactate or oxygen, ensuring that the circular hydrogel punches are always 
in contact with each other at the edges.  
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6.2.6. Characterization 
 An inverted laser spinning-disk confocal microscope (Olympus IX81) was used 
to obtain confocal fluorescence and differential interference contrast (DIC) microscopy 
images of micro domain containing MPAC hydrogels. Micro domains containing 
PdTCPP were excited with a 488 nm laser whereas micro domains containing HULK 
were excited with a 445 nm laser. Image J software was used to analyze all images. 
 
6.2.7. Sensor testing setup 
 Hydrogel samples were placed in a custom flow-through system (Figure 24) and 
exposed to varying concentrations of glucose (0-400 mg/dl), lactate (0-40mg/dl), and 
dissolved oxygen (0-206.8 µM). Two separate custom-made time-domain lifetime 
measurement systems that have been described elsewhere 101, 169 were alternately used to 
record changes in lifetime of the sensors; all data acquisition parameters were same as 
described in the previous works. Sensors containing HULK or PdBP were illuminated 
with a 630 nm LED, whereas the PdTCPP containing sensors were excited with a 530 
nm LED 169 to measure their respective luminescent lifetime responses. 
 Two mass flow controllers (type 1179A, MKS) were used to mix nitrogen and 
compressed air, in order to control the dissolved oxygen concentration (0-206.8 µM) of  
buffer (10 mM TRIS, 10 mM CaCl2 ) flowing through the flow chamber during Stern-
Volmer experiments. Different concentrations of glucose (0-400 mg/dl) or lactate (0-
40mg/dl) dissolved in buffer (10 mM TRIS, 10 mM CaCl2) were flowed over the 
hydrogel sensors to measure glucose and lactate response respectively. The response 
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curves obtained were used to extract relevant sensor response parameters: limit of 
detection (LOD), maximum differentiable glucose concentration (MDGC), analytical 
range (R=MDGC-LOD), and sensitivity. The LOD and MDGC were calculated using a 
3σ approach. The sensitivity of the sensor was assessed by computing the difference of 
the maximum and minimum response per unit analytical range. 
 
6.3. Results and discussion 
6.3.1. Characterization of microdomains 
 To demonstrate the existence of cooperative co-substrate (oxygen) depletion in 
composite hydrogel based enzymatic biosensors, we fabricated two different kinds of 
microcapsules: glucose sensing microcapsules and oxygen sensing microcapsules. 
Glucose sensing microcapsules were composed of [PDAMAC/PSS]5 -[PAH/PSS]9 
nanofilm bound microdomains containing PdTCPP and GOx, whereas oxygen sensing 
microcapsules were made by encapsulating HULK in [PDAMAC/PSS]5-[PAH/PSS]5 
bound microdomains. We studied the emission characteristics of the microcapsules 
before using them to examine cooperative effect. Figure 25A shows the emission spectra 
of both glucose sensing and oxygen sensing microcapsules when excited by 530 nm 
individually, while Figure 25B shows the emission spectra of the capsules when excited 
by 630 nm separately. Figure 25A reveals that at 530 nm excitation wavelength, 
GOx/PdTCPP containing microcapsules have a strong emission peak around 710 nm; 
however, the emission from HULK containing microcapsules around 710 nm is almost 
negligible. Similarly, at 630 nm excitation wavelength, HULK containing microcapsules 
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emit intensely around 810 nm; conversely, the GOx/PdTCPP containing microcapsules 
have insignificant emission at 810 nm.  
 
 
 
Figure 25. (A) Emission spectra of PdTCPP/GOx containing capsules and HULK 
containing capsules when excited at 530 nm, (B) emission spectra of PdTCPP/GOx 
containing capsules and HULK containing capsules when excited at 630 nm. 
 
 
 Having established that the emission peak wavelengths of the glucose sensing 
capsules and the oxygen sensing capsules are spectrally separated, and that there is 
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negligible cross-excitation when microcapsules are discretely excited at either 530 nm or 
630 nm, MPAC hydrogels containing a mixture of glucose sensing and oxygen sensing 
microcapsules were fabricated. Observing the changes in lifetime of both the glucose 
sensing and the oxygen sensing microdomains with changing glucose concentrations 
would help understand how the microdomains behave in a cooperative manner, where 
lifetime response of one microdomain is affected by its neighboring microdomains. In all 
following experiments, we recorded the lifetime emission data around wavelengths 710 
nm and 810 nm when excited at 530 nm and 630 nm respectively using custom-made 
lifetime-domain systems. 101, 169  
 
 
 
Figure 26. Nano-composite hydrogels containing both glucose and oxygen sensing 
Microdomains. (A) DIC image at 100 X magnification, (B) confocal image of GOx / 
PdTCPP containing microdomains [red], (D) confocal image of HULK containing 
microdomain [green], (C) intensity ratio image of GOx and PdTCPP containing 
microdomains under reduced oxygen to ambient oxygen, (E) intensity ratio of HULK 
containing microdomains under reduced oxygen to ambient oxygen. Scale bars correspond 
to 10 µm. Color coded scale relates to intensity ratios of GOx and PdTCPP containing 
microdomains (reduced oxygen: ambient oxygen). 
 
 
 We imaged the MPAC hydrogels using confocal microscopy (Figure 26) to 
verify the co-localization of the glucose sensing and the oxygen sensing microdomains. 
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The DIC micrograph (Figure 26A) shows a mixed population of microdomains 
immobilized inside the MPAC hydrogel. However, individual populations of either 
GOx/PdTCPP containing microdomains (Figure 26B) or HULK containing 
microdomains (Figure 26D) luminesce at their characteristic wavelengths when excited 
appropriately. Using confocal images of glucose sensing and oxygen sensing 
microdomains captured under ambient and reduced oxygen conditions we constructed 
intensity ratio images to confirm qualitatively that the oxygen quenching property of 
PdTCPP and HULK, encapsulated in the microdomains was unaffected. Intensity ratios 
in both cases increased (Figure 26C, Figure 26E), indicating that entrapped PdTCPP and 
entrapped HULK were quenched in the presence of molecular oxygen. 
 MPAC hydrogels containing GOx/PdTCPP microdomains and HULK containing 
microdomains were exposed to buffer solutions having different concentrations of 
dissolved oxygen, to quantitatively evaluate their oxygen response when co-
immobilized. A plot of the normalized lifetimes (normalized to the lifetime at zero 
oxygen concentration) of both the microdomains, against changing oxygen 
concentrations is represented in Figure 27. Using linear least-squares regression and the 
Stern-Volmer equation (τ0/τ = 1+KSV [O2]) the KSV value of the GOx/PdTCPP loaded 
microdomains was calculated to be 0.046 ± 0.002 µM-1 and the KSV  value of the HULK 
microcapsules in the MPAC hydrogel was calculated as 0.015 ± 0.001 µM-1. The 
response of both PdTCPP and HULK microdomains was noticeably linear, something 
inherent to oxygen sensitive porphyrin phosphors.127  
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Figure 27. Lifetime (normalized to the lifetime at zero oxygen concentration) against 
varying oxygen concentrations for MPAC hydrogels containing both GOx/PdTCPP micro 
domains (red ◊) and HULK microdomains (green □). Error bars represent 95% confidence 
intervals for three separate MPAC hydrogels. The dashed lines are provided only as a 
guide to the eyes. 
 
 
6.3.2. Cooperative effect   
 Microdomains that contain GOx and PdTCPP behave as optical glucose sensors. 
As glucose gradually diffuses into the interior of the microdomains, it reacts with GOx 
according to the reaction: Glucose + O2 + glucose oxidase + H2O  →  gluconic acid + 
H2O2. The enzyme-mediated reaction depletes oxygen in the process, and monitoring the 
amount of depleted oxygen allows indirect detection of the amount of glucose 
consumed. Depletion of oxygen facilitated by GOx present in one microdomain might 
also affect oxygen concentrations in the neighboring microdomains, resulting in a 
cooperative behavior. To assess this hypothesis, MPAC hydrogels containing both 
GOx/PdTCPP microdomains and HULK microdomains were exposed to different 
concentrations of glucose. Ideally, if microdomains in the MPAC hydrogel behave non-
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cooperatively, the lifetime response of the HULK microdomains would remain 
unaffected, irrespective of the concentration of glucose.  
 Figure 28A represents a plot of lifetime (normalized to lifetime obtained at 400 
mg/dl glucose concentration) against different glucose concentrations, for both non-
cross-linked nanofilm bound glucose sensing microdomains and oxygen sensing 
microdomains entrapped in MPAC hydrogels. Lifetime response recorded from both the 
glucose and oxygen sensing microdomains increase, as the concentration of glucose 
increases, suggesting that the depletion of oxygen facilitated by GOx present in the 
GOx/PdTCPP microdomains affects the oxygen concentrations in the HULK 
microdomains. Thus, the microdomains behave cooperatively with an α value of 145.7 ± 
22.0 %, where α (cooperativity coefficient) is defined as the percent increase in the 
normalized response of the HULK domains when glucose concentration is increased 
from 0 mg/dl to 400 mg/dl, as at 400 mg/ml maximum possible oxygen is depleted from 
the system. Finding a means to eliminate or reduce this cooperative effect amongst 
glucose and oxygen sensing domains would enable the construction of a hydrogel based 
sensing platform, where multiple enzymatic sensing domains can function 
independently.  
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Figure 28. Lifetime (normalized to the lifetime at 400 mg/ml glucose concentration) 
against varying glucose concentrations for MPAC hydrogels containing (A) non-cross-
linked nanofilm bound GOx/PdTCPP microdomains (red ◊) and HULK microdomains 
(green □), (B) cross-linked nanofilm bound GOx/PdTCPP microdomains (red ◊) and 
HULK microdomains (green □) and (C) cross-linked nanofilm bound GOx/PdTCPP 
microdomains (red ◊) and HULK microdomains (green □) with CAT cross-linked to the 
hydrogel matrix. Error bars represent 95% confidence intervals for three separate MPAC 
hydrogels. The dashed lines are provided only as a guide to the eyes. 
 
 
 In an attempt to decrease the amount of oxygen consumed by the glucose sensing 
microdomains, we increased the diffusion barrier around GOx/PdTCPP microdomains 
by cross-linking the nanofilm layers with glutaraldehyde. Prior studies have shown that 
restricting the amount of glucose diffusing into the GOx/PdTCPP microdomains would 
engender less oxygen consumption, which would consequently decrease cooperative 
oxygen depletion. 105, 122 Lifetime (normalized to lifetime obtained at 400mg/dl glucose 
concentration) of both glucose sensing microdomains bound by a high glucose diffusion 
barrier and oxygen sensing microdomains plotted against different glucose 
concentrations (Figure 28B), reveals that the response of the HULK microdomains 
mimics the response of the glucose sensing microdomains signifying that cooperative 
behavior still existed (α = 131.7 ± 19.6 %). Next, the concentration of the cross-linked 
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glucose sensing capsules contained within these hydrogels was decreased by ¼ times; 
although the concentration was reduced, no change in lifetime response from either the 
glucose or oxygen sensors was recorded. By lowering the concentration of glucose 
sensing capsules, the effective GOx concentration within the system was lowered to the 
extent that enough oxygen was not consumed to produce a discernible response to 
glucose by either types of microdomains; although a reduced concentration of glucose 
sensing microdomains eliminated cooperative effect completely, it rendered the glucose 
sensor inoperable. 
 Next, covalently cross-linked catalase (Cat) was introduced in the hydrogel 
matrix surrounding the cross-linked nanofilm bound glucose sensing microdomains to 
decrease the amount of oxygen consumed further. Cat reduces H2O2 (2 H2O2  → 2 H2O + 
O2) which is produced by the GOx mediated oxidation of glucose, and generates oxygen 
in the process. Increasing the oxygen contents in the vicinity of the GOx/PdTCPP 
microdomains would theoretically reduce the cooperative depletion of oxygen. Figure 
28C show the response curves of the cross-linked nanofilm bound glucose sensing 
microdomains and oxygen sensing microdomains, entrapped in alginate matrix, which 
has covalently immobilized Cat. The cooperative coefficient α drastically reduces to 4.2 
± 3.5 %, indicating that we successfully decreased the cooperative depletion of oxygen. 
However the decrease in α was achieved at the expense of losing sensor response of the 
glucose sensing microdomains, which leads us to believe that a certain degree of 
cooperativity is necessary among glucose sensing microdomains for effective analyte 
sensing. SV experiments run on hydrogels with or without immobilized Cat show no 
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significant difference in KSV  values (Figure 29A); verifying that the oxygen permeability 
characteristics were unaltered as Cat is introduced. Furthermore a control experiment 
(Figure 29B), where Cat was introduced in a hydrogel that contains oxygen sensing 
microdomains and non-cross-linked nanofilm bound glucose sensing microdomains 
revealed that cooperative effect (α = 191.4 ± 6.5 %) still existed. 
 
 
 
Figure 29. SV plot of hydrogels containing Cat (green □) and without Cat (blue ○), (B) 
non-cross-linked nanofilm bound GOx/PdTCPP microdomains (red ◊) and HULK 
microdomains (green □) with CAT cross-linked to the hydrogel matrix. Error bars 
represent 95% confidence intervals for three separate MPAC hydrogels. The dashed lines 
are provided only as a guide to the eyes. 
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6.3.3. GIG’em design 
 In a different approach to reduce cooperativity, we separated the glucose sensing 
and the oxygen sensing elements into discrete macrodomains and enclosed both the 
macrodomains within the same hydrogel (gel in gel enzymatic multiplexed sensors or 
GIG’em sensors). The glucose sensing and the oxygen sensing macrodomains consisted 
of circular MPAC punches containing glucose sensing microdomains lined by 
glutaraldehyde cross-linked [PDAMAC/PSS]5-[PAH/PSS]9 and oxygen sensing 
microdomains bound by [PDAMAC/PSS]5-[PAH/PSS]5 respectively. The circular design 
was chosen as studies conducted prior to this work (Chapter 3) have demonstrated 
circular nanocomposite hydrogels that operate at the physiological range; it should be 
noted that this study was performed to study co-operatively between sensors that 
actually work. A different form of sensor other than a circular form would require 
extensive optimization prior to performing other studies, which would digress from the 
objective of this work. Both the macrodomains were in turn entrapped within an outer 
alginate matrix, such that the glucose/oxygen sensing elements were in contact with each 
other at the edges. Figure 30A demonstrates the normalized lifetime response of the 
glucose sensing macrodomains at different glucose concentrations, when the size of the 
glucose sensing macrodomain is gradually increased. 
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Figure 30. Lifetime (normalized to the lifetime at 400 mg/ml glucose concentration) 
against varying glucose concentrations for GIG’em hydrogels containing (A) glucose 
sensing macrodomains 4 mm (red ◊), 6 mm (purple Δ), 8 mm (blue ○) and (B) their 
corresponding oxygen sensing macrodomains 4 mm (red ◊), 6 mm (purple Δ), 8 mm (blue 
○). Error bars represent 95% confidence intervals for three separate MPAC hydrogels. The 
dashed lines are provided only as a guide to the eyes. 
 
 
 The response parameters of the glucose sensors are listed in Table 3. As the 
diameter of the glucose sensing macrodomain increases from 4 mm to 8 mm the 
analytical range of the sensor gradually decreases from 232.0 mg/dl to 89.1 mg/dl. The 
decrease in analytical range is attributed to the increase in the total number of GOx 
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containing microdomains, which facilitates the rapid depletion of oxygen at a rate higher 
than the rate at which oxygen is replenished. The greater number of GOx containing 
microdomains provokes a greater degree of cooperativity within the glucose sensing 
macrodomain, which further augments the decrease of oxygen in individual glucose 
sensing microdomains. It should be noted that as we increased the size (4-8 mm) of the 
glucose sensing macrodomains the size of the adjacent oxygen sensing macrodomain 
was maintained at 4 mm. At this point, one might speculate that as the size of the 
glucose sensor is increased the cooperative effect the glucose sensor has on the adjacent 
oxygen sensor will also increase. However, examining the change in lifetime of the 
oxygen sensing macrodomain revealed that increasing glucose concentrations had 
negligible effect on it, irrespective of size of the glucose sensing macrodomain (Figure 
30B) with an average cooperative coefficient of 18.9 ± 1.2 %. The meager cooperative 
effect between the macrodomains is ascribed to local changes in oxygen concentration at 
the point of contact of the glucose sensing and oxygen sensing macrodomains, or due to 
decreased oxygen levels inside the flow cell during the enzymatic reaction irrespective 
of the size of the enzymatic sensor. Thus in this gel-in-gel (GIG) design, the major 
depletion of oxygen takes place from within the glucose sensing macrodomain, 
containing the GOx/PdTCPP microdomains, allowing desirable sensor response over the 
physiological glucose range without drastically affecting oxygen concentrations in its 
adjacent oxygen sensing macrodomain.   
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Table 3. Calculated sensor parameters for MPACs containing cross-linked [PAH/PSS]9 
bound glucose sensing microdomains with increase in size 
 
Diameter 
(mm) 
LOD  
(mg/dl)a 
MDGC 
(mg/dl)b 
Range 
(mg/dl)c 
Sensitivity/range 
(% per mg/dl) 
4 40.6 ± 2.5 272.6 ± 37.8 232.0 ± 36.2 0.5 ± 0.1 
6 8.5 ± 8.3 177.0 ± 9.5 168.5 ± 2.0 1.0 ± 0.1 
8 3.7 ± 1.7 92.8 ± 2.8 89.1 ± 1.1 3.5 ± 1.2 
 
aLOD, limit of detection; bMDGC, maximum differentiable glucose concentration; 
cRange, MDGC-LOD.  
 
 
Table 4. Calculated sensor parameters for MPACs containing non-cross-linked and 
cross-linked [PAH/PSS]9 bound glucose sensing microdomains contained in a GIG’em 
 
Microdomain 
type 
LOD  
(mg/dl)a 
MDGC 
(mg/dl)b 
Range 
(mg/dl)c 
Sensitivity/range 
(% per mg/dl) 
Non-cross-
linked 
9.0 ± 3.3 85.1 ± 18.4 76.0 ± 15.7 1.9 ± 0.7 
Cross-linked 44.5 ± 18.0 262.6 ± 33.9 218.1 ± 43.7 0.7 ± 0.2 
 
aLOD, limit of detection; bMDGC, maximum differentiable glucose concentration; 
cRange, MDGC-LOD.  
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Figure 31. Lifetime (normalized to the lifetime at 400 mg/ml glucose concentration) 
against varying glucose concentrations for GIG’em hydrogels containing (red ◊) glucose 
sensing macrodomain comprised of cross-linked GOx/PdTCPP micro domains  and (black 
Δ) glucose sensing macrodomain comprised of non-cross-linked GOx/HULK micro 
domains. Error bars represent 95% confidence intervals for three separate MPAC 
hydrogels. The dashed lines are provided only as a guide to the eyes. 
 
 
6.3.4. Multiplexed enzymatic sensors 
 Having demonstrated that we can minimize the cooperativity between sensing 
elements when enclosed in a gel-in-gel (GIG) design, we used the GIG system to 
fabricate multiplexed enzymatic sensors encapsulated in a single hydrogel matrix. 
Enzymatic sensors are flux-based systems that have a characteristic inverse relationship 
between range and sensitivity.107 Using glutaraldehyde cross-linked nanofilm bound 
microdomains the effective range of the glucose sensing element may be increased at the 
expense of losing considerable amount of sensor sensitivity, especially in the 
hypoglycemic region. 124 In order to achieve glucose sensor response over the 
physiological range (0-400 mg/dl) while maintaining high sensitivity in the 
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hypoglycemic region, we fabricated GIG’em (gel-in-gel enzymatic multiplexed) sensors 
with two macrodomains, one containing GOx/HULK microdomains bound by non-
cross-linked [PDADMAC/PSS]5-[PAH-PSS]9 and the other containing GOx/PdTCPP 
microdomains bound by glutaraldehyde cross-linked [PDADMAC/PSS]5-[PAH-PSS]9. 
Figure 31 depicts the response of the GIG’em glucose sensors, at varying glucose 
concentrations. As expected the analytical range of the GOx/PdTCPP containing 
macrodomain was ~ 191% higher than the analytical range of the GOx/HULK 
containing macrodomain, whereas the sensitivity of the GOx/PdTCPP containing 
macrodomain was ~ 183% lower than the sensitivity of the GOx/HULK containing 
macrodomain. The response parameters of the glucose detecting GIG’em sensors are 
listed in Table 4. Using this system we were able achieve an extended analytical range ~ 
218.1 mg/dl while having a high sensitivity of ~ 1.9% per mg/dl in the hypoglycemic 
region. 
 
6.3.5. Multianalyte sensor 
 We extended the concept of a multiplexed enzymatic sensor, to fabricate a 
multianalyte GIG’em sensor capable of sensing glucose and lactate independently. The 
glucose sensing component comprised of a MPAC hydrogel containing encapsulated 
GOx/PdTCPP microdomains bound by cross-linked [PDADMAC/PSS]5-[PAH-PSS]9 , 
whereas the lactate sensing component consisted of HEMA-co-AaM hydrogel punch 
containing covalently immobilized LOx, CAT and PdBP.  Figure 32A shows the 
response of both the glucose sensing and the lactate sensing components when the 
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multianalyte sensor was exposed to different concentrations of glucose. The change in 
response of the lactate sensor was ~ 0.4% when we increased the glucose concentration 
from 0 mg/dl to 400 mg/dl. Similarly, we recorded the response of both the glucose and 
lactate sensors at different concentrations of lactate (Figure 32B). The change in 
response of the glucose sensor was ~ 6.3%, as lactate concentration was varied from 0 
mg/dl to 40 mg/dl. In both cases, the characteristic response of the glucose sensor to 
changing glucose concentrations and the characteristic response of the lactate sensor to 
changing lactate concentrations was unaffected. The marginal difference in the non-
cooperative behavior of the lactate and the glucose sensor is accredited to low oxygen 
diffusivity in the lactate sensor, which engenders less oxygen depletion within the lactate 
sensor when glucose is flowed over the multianalyte GIG’em sensor. To further, 
substantiate the independent response characteristics of the multianalyte sensor we tested 
sensor response at low glucose/high lactate and high glucose/low lactate analyte 
concentrations (Figure 32C). At low glucose/high lactate (100 mg/dl glucose, 20 mg/dl 
lactate) combination the normalized lifetime for the individual sensors (glucose = 0.64 ± 
0.04; lactate = 0.72 ± 0.05) corresponds closely to the normalized lifetimes obtained 
(glucose = 0.62 ± 0.08; lactate = 0.60 ± 0.07) when only glucose or lactate is flowed. 
Similarly, the normalized lifetime for the individual sensors (glucose = 0.80 ± 0.07; 
lactate = 0.33 ± 0.03) at high glucose/low lactate concentration (200 mg/dl glucose, 10 
mg/dl lactate) tallies with the response obtained (glucose = 0.84 ± 0.03; lactate = 0.24 ± 
0.02) when only glucose or lactate is flowed separately. 
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Figure 32. (A) Lifetime (normalized to the lifetime at 400 mg/ml glucose concentration) 
against varying glucose concentrations for GIG’em hydrogels containing (red ◊) glucose 
sensing macrodomain comprised of cross-linked GOx/PdTCPP micro domains  and (blue 
□) lactate sensing macrodomain. (B) Lifetime (normalized to the lifetime at 40 mg/ml 
lactate concentration) against varying lactate concentrations for GIG’em hydrogels 
containing (red ◊) glucose sensing macrodomain comprised of cross-linked GOx/PdTCPP 
micro domains  and (blue □) lactate sensing macrodomain. (C) Lifetime (normalized to 
the lifetime at 400 mg/ml glucose/40 mg/ml lactate concentration) against varying 
glucose/lactate concentrations for GIG’em hydrogels containing (red) glucose sensing 
macrodomain comprised of cross-linked GOx/PdTCPP micro domains  and (blue) lactate 
sensing macrodomain. Error bars represent 95% confidence intervals for three separate 
MPAC hydrogels. The dashed lines are provided only as a guide to the eyes. 
 
 
 In our study, we found that in microdomain based enzymatic sensors, which 
indirectly detect analyte concentrations by measuring co-substrate (oxygen) depletion, a 
degree of cooperative oxygen depletion exists and is necessary for effective sensor 
response. Using the GIG’em design, we were successful in reducing the cooperative 
oxygen depletion between the glucose sensing component and the oxygen sensing 
component by spatially separating and confining glucose sensing and oxygen sensing 
microdomains into discrete macro sized domains. We effectively translated the GIG’em 
design to fabricated multiplexed glucose sensors, and multianalyte glucose-lactate 
sensors. 
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6.4. Conclusion 
 In this work, we have been able to demonstrate the existence of cooperative 
oxygen depletion between sensing domains contained within a hydrogel matrix for the 
first time. We have also showed that by decreasing the amount cooperative oxygen 
depletion between sensing domains, a multiplexed enzymatic sensor can be designed. By 
decreasing the amount of cooperative oxygen depletion amongst glucose sensing 
microdomains, we found that the sensing capability of the microdomains was greatly 
affected making them ineffective. Thus, micro-sized enzymatic sensors require a degree 
of cooperation to operate, which adversely interferes with potential multiplexed sensor 
design. To overcome this conundrum, we developed a GIG (gel-in-gel) design, which 
allows separate sensing domains to function independently without affecting each other. 
Using this design, the cooperative oxygen depletion within a sensing macrodomain 
remains unaffected, keeping sensor response characteristics unaltered, while having 
negligible cooperative oxygen depletion in its vicinity. Although not non-existent, the 
cooperative oxygen depletion amongst sensing macrodomains in the GIG design was ~ 
84.4% less than cooperative oxygen depletion between oxygen and glucose sensing 
microdomains entrapped within the same hydrogel. Using the developed GIG scheme, 
we successfully constructed a multiplexed glucose sensor and a multianalyte glucose-
lactate sensor. The next chapter describes the development of unique nanomaterial 
enabled microcapsule based polymeric optical sensors that may be used to detect 
enzymatic reactions as well. 
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7. GOLD NANOCLUSTER CONTAINING POLYMERIC MICROCAPSULES FOR 
RATIOMETRIC FLUORESCENCE BIOSENSING* 
 
7.1. Introduction 
 Detection of hydrogen peroxide (H2O2) has received extensive attention due to its 
relevance in chemical, environmental, clinical, and biological applications. 170, 171 H2O2 
is released as a by-product of several enzymatic reactions that enables the indirect 
detection of the reaction substrates and the tracking of enzymatic activity by monitoring 
fluctuations in H2O2 levels. 170, 172 Over the years H2O2 detection has enabled the 
development of numerous enzymatic biosensors170, 172-175 and has also permitted 
advances in enzymatic activity assays.176, 177 As stated and demonstrated in Chapter 3, 
enzyme deactivation poses to be a big problem for enzymatic sensors and H2O2 mediated 
deactivation plays a major role. All forms of enzymatic sensors are marred by enzyme 
deactivation over time that eventually leads to complete sensor failure; additionally all 
implantable devices trigger host immune response that is usually characterized by an 
increase in local H2O2 levels. Both, oxidoreductase enzyme catalyzed H2O2 release and 
macrophage mediated H2O2 have detrimental effects on the sensor’s operational lifetime; 
thus having a means to monitor H2O2 in hydrogel based enzymatic sensors is necessary 
to facilitate better sensor design.  For composite hydrogel based enzymatic sensors, it  
 
* Reprinted with permission from “Gold Nanocluster Containing Polymeric Microcapsules for 
Intracellular Ratiometric Fluorescence Biosensing” by Biswas. A., Banerjee. S., Gart. E.V., Nagaraja. 
A.T., McShane. M.J. ACS Omega 2017, 2 (6), 2499-2506.  Copyright 2017 by American Chemical 
Society. 
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would be beneficial to be able optically detect levels of H2O2. There have been a number 
of optical methods to detect H2O2 concentrations using small-molecule fluorescent 
probes, 178-182 nanoparticles, 183-185 and recombinant fluorescent proteins. 186-188 However, 
these methods utilize custom made dyes or recombinant protein that are experimentally 
difficult to make and/or often require specialized techniques (two photon detection, short 
lifetime detection). 
 Gold nanoclusters (AuNCs) have emerged as a promising tool for biosensing and 
bioimaging applications owing to their high quantum yield, large stokes shift, photo and 
chemical stability, nano-size and low toxicity. 189-191 AuNCs are usually capped by a 
protein or chemical ligand in order to enhance structural stability and photo-
luminescence characteristics. 192, 193 Bovine serum albumin (BSA) mediated 
biomineralization technique to fabricate luminescent AuNCs entrapped within BSA 
(BSA-AuNCs) has gained popularity due to its moderately high quantum yield, long 
wavelength emission, surface modification capabilities, and facile synthesis using mild 
reaction conditions. The BSA scaffold covalently interacts with the AuNCs and provides 
steric shielding, enhancing the structural stability of the AuNCs that in turn engenders 
highly stable luminescence over a broad range of pH and salt concentrations. 194 Prior 
studies have shown that the luminescence of BSA-AuNCs is sensitive to H2O2; 
potentially offering a cheaper and non-toxic alternative to commercially available H2O2 
quantification systems (e.g. o-dianisidine, tetramethylbenzidine, and 2,2-azino-bis(3-
ethylbenzothiazoline-6-sulphonicacid) ). To further take advantage of H2O2 mediated 
quenching of BSA-AuNCs, a number of optical sensing assays for analytes including 
 120 
 
glucose, cholesterol, and acetylcholine have been developed by combining BSA-AuNCs 
and substrate specific enzymes. 64, 195, 196 However, protease induced enzymatic 
degradation of the BSA scaffold can also affect the luminescence of BSA-AuNCs 197, 198 
which poses a problem for the use of BSA-AuNC enabled sensors to detect small-
molecule analytes (e.g. H2O2, glucose, lactate etc.) in complex biological samples.  
 In this work, microcapsules containing BSA-AuNCs and FluoSpheres are 
introduced as H2O2 sensors with two key features overcoming limitations of non-
encapsulated BSA-AuNCs: (1) the capsules protect the BSA-AuNCs from detrimental 
interactions with the external environment and (2) the incorporation of FluoSpheres with 
complementary emission spectra facilitates ratiometric luminescence intensity 
measurements. Micro- and nano- sized polymeric capsules fabricated with the layer-by-
layer (LbL) method have been shown as effective carriers for optical indicators in 
biosensing applications 12, 93, 96 due to the semipermeable nature of the polyelectrolyte 
multilayer (PEM) films. These LbL nanofilms physically confine the sensing reagents, 
allowing selective permeability of small molecules while excluding larger 
macromolecules and proteins 89, 199. In this case, the capsules shield the BSA-AuNCs 
from damaging proteases while permitting the free entry of analyte (H2O2).  
 The photostable fluospheres are unaffected by changes in pH 200 and therefore 
serve as a highly effective reference material when it is used in combination with BSA-
AuNCs to monitor changes in H2O2. Such an intensity reference enables ratiometric 
measurements by reducing the influence of nonspecific effects on sensor response such 
as excitation source intensity fluctuations, variations in sensor concentration, and sample 
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scattering; this is imperative for intensity based in vivo and intracellular measurements 
where there are numerous interfering factors. There are a few prior examples of BSA-
AuNC based ratiometric pH assays, forged by covalently tagging pH responsive 
fluorescein-isothiocyanate (FITC) to the amine groups of BSA-AuNCs. 201-203 These 
single-molecule sensors exhibit strong pH sensitivity, potentially making them 
susceptible to errors in tracking H2O2 fluctuations. Herein the response of the 
FluoSpheres and BSA-AuNCs containing microcapsule sensors to changes in H2O2 was 
evaluated and for the first time the use of these ratiometric microcapsule based sensors to 
sense H2O2 in vitro and in vivo (murine RAW 264.7) was demonstrated (Appendix A). 
Furthermore, the ability of these capsules to monitor glucose oxidase mediated reaction 
in order to track analyte and enzyme activity was also demonstrated.  
 
 
 
Figure 33. (A) Microcapsule based hydrogen peroxide sensor, (B) BSA-AuNC, (C) 
FluoSphere. 
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7.2. Experimental section 
7.2.1. Chemicals 
 Sodium carbonate (Na2CO3), calcium chloride (CaCl2), bovine serum albumin 
(BSA), α -chymotrypsin from bovine pancreas, trypsin from bovine pancreas, papain 
from papaya latex, proteinase K from Tritirachium album, gold (III) chloride trihydrate 
(HAuCl4.3H2O), hydrogen peroxide (H2O2), poly (sodium 4-styrenesulfonate) (PSS, 
average Mw 70000 Da), poly (diallyldimethylammonium chloride) (PDADMAC, 
average Mw 100000-200000 Da), phorbol 12-myristate 13-acetate (PMA), poly 
(vinylsulfonic acid) (PVSA), Dulbecco's modified Eagle's medium (DMEM), fetal 
bovine serum (FBS), sodium hydroxide (NaOH), phosphate buffered saline (PBS), 
buffer salts (NaHCO3, HEPES, CHES, CH3COONa), and ethylenediaminetetraacetic 
acid (EDTA) were purchased from Sigma-Aldrich and used without further purification. 
Carboxylate modified, 0.02 μm, yellow-green (505/515) FluoSpheres were obtained 
from Thermo Fisher Scientific. Glucose oxidase (GOx) from Aspergillus niger was 
purchased from BBI solutions. 
 
7.2.2. Fabrication of H2O2 sensing microcapsules 
 BSA gold nanoclusters (BSA-AuNCs) were fabricated using the green-one-pot 
synthesis method described elsewhere. 194 Briefly, 1 mL of aqueous BSA (50 mg/mL), 1 
mL of HAuCl4 (10 mM), and 100 μL of NaOH (1 M) were mixed and stirred moderately 
for 12 h at 37 OC. The resulting AuNC solution was mixed with FluoSpheres (0.78 nM) 
and 0.2 M Na2CO3 to obtain a final volume of 9 mL while maintaining the volume ratio 
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66:3:95. To the mixture 9 mL of 0.16 M CaCl2 was added and allowed to react for 10 
min at 25 °C while being stirred rapidly (800 RPM). PVSA (225 μL, 25 wt. % in H2O) 
was also added to the mixture, 2 min after the start of the reaction. PEMs were coated 
onto the BSA-AuNC/FluoSpheres loaded CaCO3 microparticles by alternately exposing 
the particles to oppositely charged PDADMAC (20 mg/mL, pH 8) and PSS (20 mg/mL, 
pH 8) until 10 bilayers were deposited. After each polyelectrolyte deposition step the 
particles were washed with NaHCO3 (5 mM, pH 8) to get rid of excess polyelectrolytes. 
To quantify encapsulation efficiency, a fraction of the cargo-loaded microparticles was 
exposed to EDTA (0.2 M, pH 7.2) to release encapsulated materials 12, 204 The relative 
amount of BSA-AuNCs and FluoSpheres released was calculated by measuring 
fluorescence intensity at 682 nm and 516 nm, respectively, when excited at 445 nm and 
by using calibration curves obtained from known concentrations of BSA-AuNCs and 
FluoSpheres. Finally, hollow microcapsules were made by suspending the PEM coated 
CaCO3 microparticles containing BSA-AuNCs / FluoSpheres in EDTA solution (0.2 M, 
pH 7.2) for 1 h followed by washing with NaHCO3 (5 mM, pH 8). Zeta potential was 
measured using a Malvern ZetaSizer Nano Series ZEN 3600 spectrometer. 
 
7.2.3. Sensitivity of sensors to proteases and to pH variation 
 Non-encapsulated BSA-AuNCs (10 μL from the prepared stock) or encapsulated 
BSA-AuNCs / FluoSpheres ratiometric sensors (made from 0.67 mg of LbL coated 
microparticles) was added to proteases solution (1mg/mL in PBS) and incubated at 37 
OC for 4 h. The control experiments were similarly conducted in the absence of 
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proteases. The relative sensor response R/ R0 was calculated where R and R0 represent 
BSA-AuNC luminescence intensities in the presence and absence of proteases 
respectively. To evaluate the sensitivity of the ratiometric sensors to pH, microcapsules 
were suspended in CH3COONa (5mM, pH 5), HEPES (5mM, pH 7), and CHES (5mM, 
pH 9) for 2 h at 37 OC. Photoluminescence measurements were made using Tecan 
Infinite M200 PRO with i-Control 1.8 software. Samples contained in black 96 well 
plates were excited at 445 nm to collect emission spectra from 500 to 800 nm. 
 
7.2.4. Sensor response measurements 
 Microcapsule sensors fabricated by dissolving 0.67 mg of PEM coated 
microparticles were incubated for 30 min at 37 °C in different concentrations of H2O2 (0 
– 1000 μM, 100 μL). H2O2 solutions were prepared using PBS and the 
photoluminescence response of the sensors at each H2O2 concentration was measured. 
For glucose sensing experiments, 0.67 mg of PEM coated microparticles suspended in 
50 μL GOx (0.6 mg/mL) were incubated for 30 min at 37 °C with different 
concentrations of glucose (0-3.2 mM) prepared in PBS. The microcapsule responses 
were measured using a Tecan Infinite M200 PRO plate reader with i-Control 1.8 
software. The luminescence intensity of composite hydrogels containing H2O2 sensing 
microcapsules was measured using an ISS PC1 spectrofluorometer connected to a 
bifurcated fiber optic bundle. Response time of the sensors when exposed to H2O2 was 
computed by evaluating the time required for the response ratio to drop by 63.2% from 
the initial ratio. 205 The limit of detection (LOD) and maximum observable peroxide 
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concentration (MOPC) was calculated by determining the H2O2 concentrations at 
R516/682(min) + 3σ and R516/682(max) - 3σ respectively, where R516/682(min) is the sensor 
response at 0 μM H2O2, R516/682(max) is the sensor response at 1000 μM H2O2, and σ is the 
standard error of the response across three separate sensor batches. The analytical range 
was calculated as Range = MOPC-LOD and sensor sensitivity was computed using S= 
[R516/682 (max) – R516/682 (min)] / R516/682 (min) · 100 / Range.  
 
7.2.5. Confocal imaging 
 All confocal and differential interference contrast (DIC) images of samples were 
obtained using an inverted microscope (Olympus IX81) having a spinning disk confocal 
unit (Yokogawa CSU-X1) and attached to an iXon897 EMCCD camera (Andor 
Technology). For confocal imaging, samples were viewed with a 40X oil immersion 
objective (1.3 NA), and excited using a 445 nm laser. Fluorescence images of 
FluoSpheres and BSA-AuNCs were captured using 525/15 nm band pass and 633 long 
pass emission filters, respectively. To image response of microcapsule sensors to varying 
concentrations of H2O2, 10 μL of microcapsule suspension was dropped on a cover slip 
for imaging. Confocal images of macrophages were obtained directly in glass bottom 
dishes. Mean luminescence intensity values were calculated from images in FluoSpheres 
and BSA-AuNC emission channels; sensor response ratios were generated by dividing 
FluoSphere mean intensity by BSA-AuNC average intensity values. Pseudocolored 
images were obtained by dividing the FluoSpheres pixel intensities by the BSA-AuNCs 
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pixel intensities. All images were analyzed using ImageJ software. Sensor parameters 
were calculated from mean sensor intensity ratios. 
7.3. Results and discussion 
7.3.1. Characterization of microcapsule sensors 
 Microcapsule based ratiometric hydrogen peroxide sensors (Figure 33A) were 
fabricated by co-encapsulating H2O2 sensitive BSA-AuNCs (Figure 33B) and H2O2-
insensitive FluoSpheres (Figure 33C). These materials have spectrally separate emission 
spectra but overlapping excitation spectra, 194, 200 which enables the use of a single 
excitation source to simultaneously excite both materials and generate dual-emission. 
Figure 34A depicts the individual emission spectra of the FluoSpheres and the BSA-
AuNCs along with the emission spectra of the microcapsule sensors containing both the 
FluoSpheres and the BSA-AuNCs. When excited at 445 nm the microcapsule sensors 
exhibited dual emission with peaks centered at 516 and 682 nm, which are similar to 
those observed when illuminating FluoSpheres and AuNCs separately. The loading 
efficiency of BSA-AuNCs and FluoSpheres was estimated to be ~ 53% and ~ 20%, 
respectively; proteins (BSA) act as additives during the nucleation process and are more 
readily adsorbed onto the surface of the primary nanocrystallites that ultimately combine 
to form the highly porous CaCO3 microstructure, resulting in higher encapsulation.167 As 
estimated from analysis of confocal images, the mean diameter of the microcapsule 
sensors was ~ 7 µm. When suspended in buffer solution (0.01 M NaHCO3, pH 8) the 
microcapsule sensors were well dispersed and showed no visible signs of aggregation; 
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zeta potential measurement revealed that the PEM-coated microcapsules had a high 
surface charge (-70.3 ± 1.4 mV) corroborating their colloidal stability.  
 Prior studies have demonstrated that degradation of the BSA shell via protease-
catalyzed hydrolysis of peptide bonds decreases BSA-AuNC luminescence intensity, 197, 
198 thereby rendering the sensors ineffective in reporting peroxide changes in the 
presence of proteases found in many biological systems. We hypothesized that 
protecting the BSA-AuNCs within LbL microcapsules would protect against this 
degradation and preserve function of the BSA-AuNC in peroxide response. The ability 
of PEMs to exclude damaging proteases and prevent quenching of the BSA-AuNCs was 
assessed by exposing the sensors to common proteases (chymotrypsin, trypsin, papain, 
and proteinase K). Non-encapsulated BSA-AuNCs showed ~ 55%, ~ 44%, ~ 37%, and ~ 
64% loss in luminescence when exposed to chymotrypsin, trypsin, papain, and 
proteinase K respectively (Figure 34B). In contrast, BSA-AuNCs encapsulated in PEM-
lined microcapsules retained their luminescence intensities (~ 100%) when exposed to 
the same proteases, (Figure 34B) indicating that PEMs exclude proteases and protect the 
luminescent reporters. Furthermore, we found no significant difference (p > 0.05) in 
luminescence of co-encapsulated FluoSpheres and BSA-AuNCs when incubated in 
different pH (5, 7, 9) solutions (Figure 35); confirming that the co-encapsulated 
FluoSpheres serve as a more robust reference material than pH-sensitive organic dyes 
such as FITC. 
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Figure 34. (A) Normalized emission spectra of FluoSpheres (green - - -), BSA-AuNC (red 
— —), and microcapsules containing both FluoSpheres and BSA-AuNC (pink —), (Inset) 
photographs of luminescent FluoSpheres, BSA-AuNC, and microcapsules containing both 
FluoSpheres and BSA-AuNC suspended in solution under UV illumination, (B) plots of 
R/R0 of non-encapsulated BSA-AuNC (dark grey stripe) and encapsulated BSA-AuNC 
(dark grey solid) in the presence of proteases. Here R and R0 represent BSA-AuNC 
luminescence intensities in the presence and absence of proteases respectively. Error bars 
represent 95% confidence intervals for three separate batches of sensors. 
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Figure 35. Ratiometric response of microcapsule sensors at different pH, normalized to 
(A) BSA-AuNC peak (682 nm) and (B) FSs peak (516 nm). Error bars represent 95% 
confidence intervals for three separate batches of microcapsule sensors. 
 
 
7.3.2. Response of microcapsule sensors to H2O2 
 The microcapsule sensors responded rapidly to the exposure of H2O2, with a 
mean response time of ~ 9 min. The change in response of the microcapsule sensors at 
varying concentrations of H2O2 was evaluated; as seen in Figure 36A an increase in 
H2O2 concentration decreased the emission of the BSA-AuNCs progressively, while the 
emission of the FluoSpheres remained relatively constant. By plotting the intensity ratios 
(I516 / I682) against H2O2 concentrations (Figure 36B) two distinct linear regions in the 
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range 0-200 µM (R2=0.98) and 200-1000 µM (R2=0.98) were observed. These findings 
are similar to the quenching profiles reported previously for BSA-AuNCs. 64, 201 The 
average LOD, MOPC, analytical range and sensitivity per unit range were ~ 26.20 µM, ~ 
858.5 µM, ~ 832.7 µM, and ~ 0.2% / µM, respectively. Subsequently, these sensors were 
imaged using confocal microscopy at various H2O2 concentrations. Microcapsules were 
incubated in different H2O2 concentrations and were imaged to obtain average 
luminescence intensity ratios. Figure 36 D-F contain representative pseudocolored 
images of microcapsules at 0 µM, 400 µM, and 1000 µM H2O2 respectively. Figure 36D 
is predominantly blue, characteristic to a low mean intensity ratio (0.56 ± 0.04) whereas 
Figure 36F has a mixture of yellow-red microcapsules representing a higher mean ratio 
(1.58 ± 0.06) and Figure 36E has a green microcapsule population with an intermediate 
mean ratio (1.25 ± 0.03). By plotting the mean intensity ratios acquired from confocal 
imaging against H2O2 concentrations, a response curve (Figure 36C) analogous to that 
obtained using the plate reader was obtained. Similar to Figure 36B, Figure 36C reveals 
a ratiometric response with two separate linear regions spanning 0-200 µM (R2=0.99) 
and 200-1000 µM (R2=0.97). The average LOD, MOPC, analytical range and sensitivity 
per unit range were found to be ~ 34.90 µM, ~ 619.8 µM, ~ 584.9 µM, and ~ 0.3% / µM 
respectively; the differences in calculated sensor parameters between the data acquired 
using spectrophotometry and confocal microscopy, is ascribed to the differences in the 
optical set-ups used to collect data.  
 If these microcapsules are immobilized in a glucose sensing hydrogels containing 
GOx and Cat, the capsules could potentially monitor the gradual release of H2O2 over 
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time as micromolar levels of H2O2 can drastically reduce sensor performance. It is 
known that in two enzyme sensor systems, Cat scavenges H2O2 produced via enzymatic 
reactions that drive the sensor; this enhances the longevity of the analyte specific 
enzyme (GOx in this case) and Cat as well. It should also be noted that Cat is more 
susceptible to H2O2 mediated deactivation than GOx, as such the concentration of Cat in 
enzymatic sensors has traditionally been greater than GOx concentration.51, 206 Having a 
method to optically detect low levels of H2O2 release would be extremely useful in better 
sensor design. 
 
7.3.3. Use of microcapsule sensors to monitor enzymatic reactions  
 Before incorporating the microcapsules in hydrogels the response of these 
sensors to enzymatic reactions that generate H2O2 was evaluated, while the capsules 
were suspended in solution. Although, this dissertation is focused on using these 
microcapsules to monitor enzymatic activity and H2O2 release in hydrogels, these 
microcapsules may also be used to detect physiologically relevant analytes in vitro, when 
coupled with an appropriate enzyme. We evaluated the response of these microcapsules 
at constant GOx concentration while increasing glucose concentration; with increase in 
glucose concentration the fluorescence intensity (Figure 37A) decreases progressively at 
682 nm while intensity at 516 nm remains constant. A plot of the intensity ratio I516 / I682 
(Figure 37B) reveals that the ratio increases with increasing glucose, having high 
linearity (R2=0.99) between 0.08-0.8 mM glucose; the average LOD, MOPC, analytical 
range and were found to be ~ 0.06 mM, ~ 1.23 µM, and ~ 1.17 µM respectively. These 
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experiments not only underscore the use of the microcapsules to monitor enzymatic 
reactions but it also demonstrates that the microcapsules can be used to in vitro detection 
of glucose, especially in biological samples as the sensing chemistry is protected by the 
capsule walls.  
 
 
 
Figure 36. (A) Emission spectra of microcapsules containing both FluoSpheres and BSA-
AuNC to 0 µM (black), 20 µM (purple), 40 µM (blue), 60 µM (maroon), 80 µM (navy 
blue), 100 µM (orange), 200 µM (bright red), 400 µM (pink), 600 µM (green), 800 µM 
(red), and 1000 µM hydrogen peroxide (light blue), mean ratiometric response of 
microcapsules containing both FluoSpheres and BSA-AuNC to varying concentrations of 
hydrogen peroxide obtained using microplate spectrophotometer (B) and obtained using 
ratiometric images (C) of microcapsules. Confocal, ratiometric fluorescence images of 
microcapsules containing both FluoSpheres and BSA-AuNC at (D) 0 µM, (E) 400 µM, 
and (F) 1000 µM hydrogen peroxide. Pseudocolored images represent the ratio of 
emission intensities collected using 510-540 nm band pass filter and 633 long pass filter, 
when excited at 445 nm. Scale bars correspond to 20 µm. Error bars represent 95% 
confidence intervals for at least three separate samples of microcapsule sensors. 
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7.3.4. Incorporation of microcapsules into hydrogels 
 The microcapsule sensors were designed to potentially monitor the release of 
H2O2 over time, when hydrogel based glucose or lactate sensors were subjected to 
extreme glucose or lactate levels. Just like other optical H2O2 reporters, BSA-AuNCs are 
quenched cumulatively and non-reversibly by H2O2, thus they cannot measure the 
instantaneous level of H2O2 within a dynamic system (e.g. within an enzymatic hydrogel 
sensor). However, this is a step forward in the right direction as measuring H2O2 
liberation within hydrogel based sensors would provide insights to design more stable 
enzymatic sensors. That being said, due to instrumentation constraints it was not possible 
to obtain discernible signal from capsules entrapped inside hydrogels. Before even moving 
on to hydrogel based sensors, the capsules were immobilized in hydrogels that do not 
contain any sensing chemistry. First, capsules fabricated from 0.67 mg, 6.7 mg, and 13.4 mg 
of calcium carbonate particles were disperse in an alginate precursor-mix to fabricate 
composite alginate hydrogels (for details refer to section 3.2.5). Even with a really high 
concentration of microcapsules no distinct emission peaks were observed when excited 
appropriately (300-450 nm); we speculate that a high degree of scattering from the hydrogel 
and the capsules produces a low signal-to-noise ratio, prohibiting any emission intensity 
measurements. A different hydrogel, HEMA-co-Aam was also used for microcapsule 
immobilization; this hydrogel allows more transmission of light and thus is a better 
candidate to immobilize the capsule based optical sensors. However, even with HEMA-co-
Aam we could not obtain any emission signal from immobilized capsules fabricated from 
0.67 mg, 6.7 mg, and 13.4 mg of calcium carbonate particles. It seems that at such short 
excitation wavelengths that inherently engender a high degree of scattering, it would be 
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logical to use an excitation source with a higher intensity or to use a two photon system. A 
two photon system would enable the use of longer wavelengths to excite the microcapsules; 
longer excitation wavelengths would mitigate excessive scattering which might lead to a 
better signal-to-noise ratio. However, due to unavailability of such instruments these 
experiments were not further pursued. 
 
 
 
Figure 37. (A) Emission spectra of microcapsules containing both FluoSpheres and BSA-
AuNC to increasing glucose, (B) mean ratiometric response of microcapsules containing 
both FluoSpheres and BSA-AuNC to varying concentrations of glucose obtained using 
microplate spectrophotometer. Error bars represent 95% confidence intervals for at least 
three separate samples of microcapsule sensors. 
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7.4. Conclusion 
 A method to fabricate polymeric microcapsule-based ratiometric H2O2 sensors 
was demonstrated using a combination of BSA-AuNC and a reference fluorescent 
nanoparticle. The microcapsules are beneficial for direct detection of H2O2, in 
applications that involve complex biological samples. Additionally, it is noteworthy that 
BSA-AuNCs have also been used for environmental monitoring of hazardous materials 
(e.g. Hg2+, cyanide)207, 208; thus, the ratiometric microcapsule-based platform may also be 
advantageous for use in similar applications. Ratiometric sensing facilitates reliable 
measurements and the semi-permeable nature of the LbL microcapsule walls protects the 
BSA-AuNCs from catalytic enzymes and non-specifically binding macromolecules. The 
microcapsule sensors were also used to monitor glucose oxidation by GOx in order to 
determine glucose concentration changes. Potentially these H2O2 sensors could be 
coimmobilized in enzymatic hydrogels to track release of H2O2 over time; however, 
neither FluoSphere nor BSA-AuNC emission signal could be detected. 
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8. CONCLUSIONS AND FUTURE DIRECTIONS 
  
 This work has shown the ability to use PEMs as the lining to microdomains 
containing encapsulated sensing chemistry, and particularly that these PEMs 
significantly affect the overriding response characteristics of nanocomposite enzymatic 
sensors. It was possible to tune the diffusion of a model analyte (glucose) over a rather 
wide range by changing the multilayer composition and also by chemical cross-linking. 
This capability to adjust response is critical to engineering devices that function well in 
different environments (e.g. in vivo, interstitial fluid, inflamed tissue), where substrate 
delivery may be altered from normal. The substrate permeation rate may be precisely 
regulated by changing the layer composition or number of spacer bilayers, as these 
factors determine the extent of intralayer and interlayer crosslinking. On average, the 
cross-linked films showed ~86 % decrease in glucose diffusion compared to non-cross-
linked films, without affecting corresponding oxygen permeation. The cross-linked 
microcapsule sensors embedded in an MPAC hydrogel demonstrate the potential for 
complete control over relevant analytical range and sensitivity between 3 and 9 cross-
linked layers. It is expected that use of other materials with alternative reactive side 
groups as well as deposition under different conditions to alter film structure (e.g. pH, 
salt control over polyelectrolyte conformation) will enable additional adjustment of 
diffusion. This provides a powerful tool to tune the dynamics of any flux-based system, 
which includes sensors such as the model glucose system explored here as well as 
controlled-release systems for medicines, fertilizers, self-healing materials, etc. 
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Although these nanocomposite glucose sensors showed promise for use as implantable 
sensors, sensor stability studies revealed that these hydrogel sensors, which were 
fabricated by using CaCO3 templates were highly unstable for long term. The lifetime 
response of these sensors progressively deteriorated > 50% within 3 days of continuous 
glucose exposure. The loss in sensor response was attributed to GOx deactivation 
overtime, prompting the search for alternative GOx encapsulation templates to enhance 
GOx stability.  
 GOx is highly susceptible to deactivation by spontaneous enzyme denaturation 
and via H2O2 mediated inactivation.110 In case of enzymatic glucose sensors, deactivated 
GOx leads to drifting sensor response over time requiring frequent recalibrations 
eventually leading to complete sensor failure. Researchers have investigated various 
techniques to alleviate GOx deactivation in order to prolong a sensor’s operational 
lifetime. To reduce enzyme deactivation in the nanocomposite glucose sensors prepared 
by GOx encapsulation in CaCO3 microparticles, two strategies were employed: (1) 
introduction of Cat and (2) immobilization of GOx in a polymeric matrix. H2O2 
irreversibly causes enzyme deactivation especially under low oxygen conditions; this is 
particularly important as the hydrogels sensors are designed for tissue implantation 
where oxygen levels are significantly lower than ambient oxygen.110 Furthermore, in 
continuously operating sensors H2O2 mediated GOx inactivation contributes to the 
majority of enzyme activity loss. The released H2O2 can be easily counteracted by Cat 
facilitated catalysis of H2O2 that produces H2O and O2. Thus, we introduced a second 
enzyme Cat in our sensors to assuage H2O2 mediated GOx inactivation. Additionally, it 
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has also been proven that enzyme stability is enhanced when enzymes are immobilized 
in polymer matrices. This is due to stabilization of the enzyme’s tertiary structure via 
interactions with the surrounding polymer matrix.150 Therefore, we replaced the hollow 
microcontainers with alginate hydrogel microspheres that contain sensing chemistry. 
Oxidoreductase based enzymatic sensors usually contain excess Cat in order to reduce 
the rate of GOx inactivation.209 Ideally, it would be advantageous to have a higher 
concentration of Cat in the hydrogel microspheres; however, it should be remembered 
that an increased Cat concentration would reduce sensor sensitivity drastically.  
 An updated and a newer generation of nanocomposite hydrogels was developed 
using AMPs containing PdTCPP, GOx, and Cat. The versatility of the LbL process 
allows the deposition of LbL coatings on a variety of micro- and nano- sized colloidal 
templates; thus the cross-linked PAH/PSS diffusion barrier was easily translated onto 
bioactive AMPs that were used to make AnA sensors. These sensors outperformed all 
other generations of optical hydrogel based glucose sensors by having: (1) a wide 
analytical range while operating at physiologically low oxygen levels and (2) a high 
degree of sensor signal retention under continuous operation. The AnA sensors exhibited 
an analytical range of 2.6 – 350 mg/dL glucose at low oxygen, and it was estimated that 
the sensor response would drop by 50% if exposed to ~173 intermittent bursts of high 
glucose over 2 weeks. Furthermore, to establish the versatility of this sensor design 
lactate sensors were developed; for the first time nanocomposite hydrogel based optical 
lactate sensors that operate at physiologically low oxygen was demonstrated. These 
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sensors revealed exceptional sensitivity in the range 4.5 – 13.5 mg/dL of lactate at low 
oxygen and were extremely stable under continuous operation.  
 Although both the glucose and the lactate sensors perform extraordinary well at 
low oxygen and similar nanocomposite hydrogels have shown good tissue integration 
with minimal host response in animal studies (data not shown), there are certain 
limitations.  The major drawback is the use of green excitable phosphor PdTCPP for in 
vivo applications. The complex nature of skin causes absorption and scattering of 
photons when light is either incident (excitation) on skin or emanating (emission) from 
skin; thus, hindering unaltered propagation of light leading to reduced signal-to-noise 
ratio. Early research pertaining to tissue optics identified 600 - 1300 nm as the optical 
window where there is minimal scattering and absorption of light from tissue.17 
Although PdTCPP emits around 700 nm, its 530 nm (green) excitation wavelength 
causes low signal-to-noise ratio when collecting data from implanted hydrogel sensors. 
Substituting PdTCPP with another phosphorescent metalloporphyrin dye that has longer 
excitation and emission wavelengths would allow greater light penetration into tissue 
and solve the low signal-to-noise ratio problem. Both commercially available and 
custom made metallo-benzo-porphyrins that are red excitable (~700 nm) and emit in the 
near infrared region (~830 nm) may be used as alternative optical indicators. However, 
metallo-benzo-porphyrins are usually less sensitive to oxygen (low lifetime when 
unquenched), which would mandate careful sensor response optimization. Another 
aspect that may be altered is the alginate matrix that houses the nanofilm bound 
microspheres; the outer hydrogel matrix interacts with the body physiology when 
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implanted and plays a huge role in biocompatibility. The alginate hydrogel matrix can 
potentially be replaced by other antifouling hydrogels (e.g. poly(ethylene glycol) 
diacrylate,210 poly (hydroxyethyl methacrylate),211 poly-L-lactic acid,212 poly (vinyl 
alcohol)213) or foul releasing hydrogels (e.g. poly( N -isopropylacrylamide) based 
copolymers214, 215). However, depending on the matrix used the permeability of analyte 
(glucose or lactate) would change and mandate reoptimization of the nanofilms that coat 
the microspheres. It should also be noted that the glucose and lactate sensors discussed 
in this dissertation are in the form of hydrogel discs, which cannot be implanted easily; 
ideally the sensors should be small enough to fit a ~18 gauge needle in order to be 
subcutaneously implanted. Nevertheless, any changes in sensor size would require 
further sensor response optimization as well. For a particular optical reporter and sensor 
size-shape combination, several parameters may be altered to modulate sensor response; 
these parameters include relative amounts of encapsulated enzyme (GOx, LOx, and Cat) 
in each microdomain, number of microdomains per unit volume of the hydrogel sensors, 
and the rate of permeation of analyte into the microdomains. 
 Cooperative effect, a phenomenon characteristic to any enzyme based 
nanocomposite hydrogel sensor was also demonstrated. Understanding cooperative 
effect is imperative to design a future generation of multiplexed, multimodal, or 
multianalyte enzymatic sensors. Using glucose sensing and oxygen sensing 
microdomains it was found that enzyme-based microdomain sensors embedded within a 
hydrogel matrix affect local oxygen concentrations in a cooperative fashion; oxygen 
levels and hence optical response of a particular enzymatic microdomain was influenced 
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by other surrounding microdomains. Hypothetically it might seem possible to elicit 
independent sensor response by entrapping different types of bioactive microdomains 
within the same matrix; however experiments revealed that it was near impossible to 
achieve independent response without losing individual sensor response. In order to 
achieve independent multianalyte and multi-functional sensing we developed the 
GIG’em design for hydrogel based sensors; this design lays the groundwork to develop 
implantable multiplexed sensors. Once enzymatic sensors that operate at physiological 
conditions are miniaturized sufficiently to allow direct implantation the GIG’em design 
may be used to fabricate dual- or multi- analyte sensors. This design would also allow 
the introduction of reference oxygen sensors to correct for internal oxygen fluctuations 
when using enzymatic glucose and lactate sensors. 
 Finally, a new microcapsule based ratiometric H2O2 sensor is introduced for 
potentially monitoring enzymatic reactions in hydrogel based enzymatic sensors (e.g. 
glucose sensor, lactate sensor). Although preliminary results using a plate reader were 
promising, it was not possible to obtain any emission signal from such microcapsules 
immobilized in hydrogel matrices. This could possibly be due to intense scattering of 
lower wavelength excitation light incident on hydrogels; this limitation can probably be 
circumvented by using a higher power excitation source or a two photon excitation 
system. The current generation of AlgMP based glucose and lactate sensors have been 
shown to be highly stable under near physiological conditions, as such there is no urgent 
need to develop a system to monitor H2O2 release inside hydrogel sensors. However, 
with proper instrumentation and by using other H2O2 probes, preferably with long 
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wavelength excitation and emission characteristics, enzymatic activity inside hydrogel 
sensors might be easily tracked. 
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APPENDIX A 
H2O2 is a reactive oxygen species and an important metabolite in living systems 
acting as a biomarker for oxidative stress and an indicator of cell damage. 216, 217 Over 
the years it has also been established that H2O2 is of paramount importance for cellular 
signal transduction pathways. 218, 219 In mammals, H2O2 has been associated with 
triggering immune cell response cascades and remodeling injured vasculature. 220 
Physiological levels of H2O2 fluctuate in the micromolar range and under pathological 
conditions H2O2 concentrations may rise to millimolar levels. 181, 221The multifaceted 
role of H2O2 in biochemical processes has motivated research to quantify and image 
cellular H2O2 concentrations using different methods (small-molecule fluorescent 
probes, 178-182 nanoparticles, 183-185 and recombinant fluorescent proteins 186-188 ) After 
evaluating the response of the FluoSpheres and BSA-AuNCs containing microcapsule 
sensors to changes in H2O2 (Chapter 7), herein the use of these ratiometric microcapsule 
based sensors to image H2O2 in murine RAW 264.7 macrophage cells was demonstrated 
for the first time. 
* Reprinted with permission from “Gold Nanocluster Containing Polymeric Microcapsules for
Intracellular Ratiometric Fluorescence Biosensing” by Biswas. A., Banerjee. S., Gart. E.V., Nagaraja. 
A.T., McShane. M.J. ACS Omega 2017, 2 (6), 2499-2506.  Copyright 2017 by American Chemical 
Society. 
INTRACELLULAR RESPONSE OF GOLD NANOCLUSTER CONTAINING 
MICROCAPSULE BASED H2O2 SENSORS* 
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A.1 Cell culture  
 For methods to fabricate the microcapsule sensors and confocal imaging 
techniques please refer to Section 7.2. Murine macrophage cells (RAW 264.7) were 
cultured in DMEM, containing high glucose and 10% FBS. The cell cultures were split 
(1/6) twice a week. A day before incubating the cells with the microcapsule sensors, the 
cells were passaged and seeded at a density of 3 X 104 cells/dish in 35 mm glass bottom 
dishes (Cellvis). For all sensor-response experiments, cells were incubated at 37 OC and 
5% CO2 with microcapsule sensors (fabricated from 6.7 mg of PEM coated 
microparticles) for 1 h. However, cells were incubated with the sensors for 24 h for the 
cell vitality assay analysis. Before imaging, all cells were moderately washed with PBS 
to remove unbound cells and excess microcapsule sensors. PMA (1 mg/mL stock) and 
H2O2 (10 mM stock) were directly added to cell culture media and incubated for 30 min 
before imaging. For cell vitality assay experiments, cells were incubated with 3 mL PBS 
containing calcein AM (2 µM) and ethidium homodimer (1 µM) for 15 min. 
 
 
 
Figure A 1. (A) Microcapsule sensors incubated with macrophages, (B) microcapsule 
sensors being engulfed by macrophages, (C) microcapsule sensors ingested by 
macrophages. 
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A.2 Intracellular response of microcapsule sensors 
 Confocal and DIC images of RAW 264.7 macrophages incubated with 
microcapsule sensors for one hour indicated that the microcapsules were rapidly and 
effectively ingested by the cells (Figure A3 A-F). In comparison to macrophages that 
had not been incubated with microcapsules (Figure A3 F inset), the microcapsule-
containing macrophages appear to be granular when viewed using DIC; this is ascribed 
to local optical-path gradients introduced by the internalized microcapsules. Using 
standard cell vitality assays, it was confirmed that the viability of the cells was unaltered 
after microcapsule ingestion (Figure A2). The mean intensity ratio (Figure A3 G) of the 
microcapsules ingested by the cells (Figure A3 A) was estimated to be 125% more than 
the ratio of the microcapsules that were not ingested (Figure A4 B) but present in the 
vicinity of the macrophages. The increase in ratio is attributed to the inherent H2O2 
release by the macrophages to degrade the phagocytosed foreign materials. Treatment of 
the microcapsule-loaded cells with 500 µM H2O2 (Figure A3 B) served as a positive 
control and triggered an increase in ratio (Figure A3 G) of both the microcapsules inside 
the cells as well as the microcapsules present outside (Figure A4 D). The response of the 
extracellular microcapsules increased by 123% whereas the sensor response of the 
phagocytosed microcapsules increased by 35%. To further demonstrate the feasibility of 
the microcapsule based sensors to detect endogenous release of H2O2 in response to 
stimulants, the sensor-loaded cells were imaged after the cells were stimulated with 
PMA (Figure A3 C). The response (Figure A3 G) of the microcapsules outside the cells 
(Figure A4 F) was almost unaltered while the response of the sensors inside the cells 
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increased by 21%. This provides strong evidence that the macrophages release 
endogenous H2O2 in response to PMA stimulus, as reported by the internalized sensors, 
while the external sensors did not respond. These results demonstrate the benefit of 
BSA-AuNC microcapsule ratiometric sensors for imaging physiological H2O2 and 
detecting endogenous bursts of H2O2.  
 
 
 
Figure A 2. Vitality assay of RAW 264.7 macrophages. CAM emission channel of (A) 
macrophages loaded with microcapsule sensors, (D) macrophages not incubated with 
microcapsule sensors [positive control], (G) macrophages treated with bug buster 
detergent (1X) [negative control]. Ethidium homodimer emission channel of (A) 
macrophages loaded with microcapsule sensors, (D) macrophages not incubated with 
microcapsule sensors [positive control], (G) macrophages treated with bug buster 
detergent (1X) [negative control]. (C), (F), and (I) DIC images of cells in panel (A, B), 
(D, E), and (G, H) respectively. Scale bars correspond to 50 µm. 
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 To summarize, intracellular H2O2 fluctuations in response to external stimuli 
were detected. Given the excellent sensitivity and wide range of the response, these 
sensors may be potentially used to study cellular signaling pathways that involve low 
levels of H2O2 generation. Compared to other commercially available H2O2 detection 
assays, this microcapsule based system presents as an inexpensive and a non-toxic 
substitute. However, it is important to appreciate that internalization of microcapsules 
will depend, to a degree, on the external surface charge they present as well as the 
specific cells involved. It is therefore worth noting that these microcapsules are highly 
tailorable; the types of polyelectrolytes used and the conditions (e.g. pH, ionic strength) 
used during fabrication can easily alter capsule properties. For example if the intended 
application mandates a positive surface charge, the surface charge of our capsules can be 
easily changed to positive by switching the outer layer to a cationic polyelectrolyte (e.g. 
PDADMAC, poly(allylamine) ). 
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Figure A 3. Confocal fluorescence images of RAW 264.7 macrophage cells. 
Pseudocolored images represent the ratio of emission intensities collected using 510-540 
nm band pass filter and 633 long pass filter, when excited at 445 nm. (A) Cells incubated 
with microcapsules for 1 h at 37 OC, (B) microcapsule loaded cells after PMA (2 µg/mL) 
exposure for 30 min at 37 OC, and (C) microcapsule loaded cells after H2O2 (500 µM) 
exposure for 30 min at 37 OC. (D), (E), and (F) DIC images of cells in panel (A), (B), and 
(C) respectively. Scale bars correspond to 30 µm. (G) Ratiometric response of 
extracellular (dark grey stripes) and intracellular (dark grey solid) microcapsule sensors. 
Error bars represent 95% confidence intervals for three separate batches of microcapsule 
sensors. 
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Figure A 4. Confocal ratiometric fluorescence images of RAW 264.7 macrophage cells. 
Pseudocolored images represent the ratio of emission intensities collected using 510-540 
nm band pass filter and 633 long pass filter, when excited at 445 nm. (B) Cells incubated 
with microcapsules for 1 hr at 37 OC, (D) microcapsule loaded cells after H2O2 (500 µM) 
exposure for 30 mins at 37 OC, and (F) microcapsule loaded cells after PMA (2 µg/mL) 
exposure for 30 mins at 37 OC. (A), (C), and (E) DIC images of cells in panel (B), (D), 
and (F) respectively. Scale bars correspond to 50 µm. Blue arrows point to extracellular 
microcapsule sensors whereas red arrows point to microcapsule loaded cells. 
 
